Entities

Mechanical engineer and financial analyst with experience leading technology companies and serving on portfolio boards.

Life-sciences researcher and technology-transfer specialist with experience in medical incubation and research-based investment sourcing.

Finance adviser with experience in financial administration, strategy, organizational development and mergers and acquisitions.

Consultant overseeing regulatory compliance and governance, with a background in investment banking and asset management.

Experienced in business development, corporate finance, investment management and leading research-funding foundations.

Harjavalta Group is a Finnish family office and industrial holding group with roots in wood processing and construction. It invests in listed and private companies, grows its operating businesses and backs startups through Harjavalta Ventures. Its long-term investment strategy targets internationally scalable businesses with competitive advantages, including opportunities driven by the green transition, urbanisation, digitalisation and health. It acts as a majority owner of operating companies, an active owner in startups and a significant shareholder in listed companies.

Harjavalta Ventures is the early-stage investment subsidiary of Harjavalta Group, a Finnish family office and industrial holding group. It backs startups as part of the group’s long-term expansion beyond its construction and wood-processing businesses. The parent seeks internationally scalable businesses with a competitive advantage and growth driven by digitalisation, health, the green transition and other major economic trends. Harjavalta Ventures participated in AIATELLA’s EUR2 million cardiovascular-imaging financing announced in June2025.

Andra Bagdonaitė is a FIRSTPICK general partner and co-founder. Her experience spans entrepreneurship and coding education, consulting at Civitta, and investment management at Startup Wise Guys. At FIRSTPICK she leads investments, brand and limited-partner engagement while supporting founders from the earliest stages.

Anna-Karoliina Aine is a registered board member of Harjavalta Ventures Oy, the early-stage investment subsidiary of Finland’s Harjavalta Group. The official current Finnish trade-register extract identifies this subsidiary governance appointment; the parent group publishes the same person in its own governance and contact directory. This board affiliation does not establish subsidiary employment or an executive investment-management title.

Dmitrij Sosunov is FIRSTPICK’s managing partner and a co-founder. He has entrepreneurial experience across businesses that failed and exited, followed by management consulting in business development, coaching, operations and leadership. He previously managed a fund with Jonė Vaitulevičiūtė and advises FIRSTPICK founders on product-market fit, sales and strategy.

Elina Annikki Aine-Simonen is a registered board member of Harjavalta Ventures Oy, the early-stage investment subsidiary of Finland’s Harjavalta Group. The official current Finnish trade-register extract identifies this subsidiary governance appointment; the parent group publishes the same person in its own governance and contact directory. This board affiliation does not establish subsidiary employment or an executive investment-management title.

Jonė Vaitulevičiūtė is a general partner and co-founder of FIRSTPICK. Her career includes IBM, startup advisory work at Civitta and Startup Division, and managing a venture fund under Startup Wise Guys before FIRSTPICK. She supports fundraising, strategy and metrics, with interests in marketplaces, wellness technology and fintech.

Jussi Aimo Samuli Aine is a registered board member of Harjavalta Ventures Oy, the early-stage investment subsidiary of Finland’s Harjavalta Group. The official current Finnish trade-register extract identifies this subsidiary governance appointment; the parent group publishes the same person in its own governance and contact directory. This board affiliation does not establish subsidiary employment or an executive investment-management title.

Kaj-Gustaf Johan Bergh is a registered chairman of the board of Harjavalta Ventures Oy, the early-stage investment subsidiary of Finland’s Harjavalta Group. The official current Finnish trade-register extract identifies this subsidiary governance appointment; the parent group publishes the same person in its own governance and contact directory. This board affiliation does not establish subsidiary employment or an executive investment-management title.

Marijus Andrijauskas is a FIRSTPICK general partner and co-founder with international software-business management, strategy, sales, marketing and operating experience. He founded technology businesses including Teamgate and later worked with a large accelerator portfolio. He mentors FIRSTPICK founders on strategy, fundraising, investor presentations and business planning.

Nikodemas Valiušaitis is FIRSTPICK’s finance and compliance associate. He studied economics at Vilnius University and Ryukoku University in Japan, and previously worked in technology sales, financial modelling and product implementation. He supports the manager’s legal processes and fund operations, bringing an analytical approach to venture finance.

Rūta Sičiūnaitė is an investment analyst at FIRSTPICK. Her background includes strategy, finance and market analysis at Civitta and PwC and work at a software startup on planning, go-to-market strategy and finance. She researches prospective founders and develops investment cases with the firm’s partners.

Tadas Gudauskas is FIRSTPICK’s head of platform. Earlier experience includes Invest Lithuania and the Lithuanian Embassy in India, where he worked on Lithuania’s business proposition in Bangalore. He now builds the networks, practical support and shared knowledge available to portfolio founders.

Anodyne Nanotech is a Boston biotechnology company developing transdermal delivery systems for chronic medicines. Its HeroPatch contains solid porous microneedles loaded with drug molecules; after application, fluid in the skin releases the medicine by diffusion while the needle structures remain intact and are removed with the patch. The platform is designed for multi-milligram doses of peptides and biologics, adjustable release profiles and solid-state formulations that reduce cold-storage requirements. Its development pipeline includes ANN-101, a once-weekly GLP-1 receptor agonist patch for obesity, ANN-102 targeting the APJ receptor for muscle loss, and a combined GLP-1/APJ program for sarcopenic obesity. These are development candidates rather than approved therapies.

Proteine Resources is a Polish biotechnology company producing insect-based ingredients and pet food. It uses mushroom-industry by-products as feed for buffalo mealworms and processes the larvae into EntoPro, a functional protein ingredient intended to support pet nutrition and gut health. Its production system combines patented feeding processes with robotics, machine vision and AI-supported control of insect breeding and factory operations. The company supplies protein ingredients and private-label wet food and has developed the Veli pet-food brand. It is scaling modular production facilities near agricultural by-product sources to improve consistency and resource efficiency.

Entrepreneur with experience in enterprise sales, fundraising and scaling companies.

R&D leader with a University of Rhode Island PhD and experience at Arch Therapeutics, Medtronic, Biolink and C.R. Bard.

Insect breeding specialist named as a co-founder in the company’s own team publication.

Physicist working on micro/nanofabrication and drug delivery, previously affiliated with Tufts and Harvard-MIT.

Biomedical engineer with degrees from Union College and Tufts University.

Insect breeding and process development entrepreneur.

Electrical and computer engineer educated at NTUA and Tufts University.

Medical device and biotech operator with previous leadership roles at Becton Dickinson.

Former LucasArts creative director and engineer identified in Akili’s2022 prospectus among the founding contributors who developed its video-game therapeutic technology. Historical founder affiliation; current operating role unverified.

Virtual Therapeutics finance and operations executive who became Akili’s treasurer and secretary on July2,2024 following the acquisition. Last-confirmed legal appointment is distinguished from an unverified current operating title. The May31,2024 parent tender identifies him as Virtual Therapeutics Vice President Operations and Finance. He served as Director Business Management for Microsoft Game Studios’ Turn10 and Playground Games2019–2021 and previously held Xbox third-party gaming-finance roles2008–2019, most recently Group Finance Manager. He has a BS in Finance from Brigham Young University and an MBA from the University of Washington. No authenticated original portrait was verified in retrieved parent sources.

Akili co-founder and former LucasArts executive art director, identified in its2022 securities prospectus as helping translate early cognitive-neuroscience research into video-game therapeutic technology. Historical founder affiliation; no current executive title inferred.

Former Merck research executive and University of Washington biochemistry chair named to Akili’s clinical advisory committee November2018. This is a dated historical scientific-advisory affiliation.

Biogen executive named to Akili’s clinical advisory committee in November2018; this advisory affiliation is dated and current service is unverified.

Daniel (Dan) J. Elenbaas became Akili’s sole director and president on July2,2024 following acquisition by Virtual Therapeutics, where he was co-founder and CEO. The SEC closing filing establishes the appointment; no later public officer roster has been verified. Primary May31,2024 parent tender identifies him as Virtual Therapeutics president, CEO and director since its founding in2015, retaining majority shareholder control after institutional minority financing. He founded and led Clearshift2012–2017 and Amaze Entertainment1996–2007, and served on Foundation9 Entertainment’s board2007–2016. He earned a BA in Political Science at Brigham Young University. His native vthera.com DanE.png portrait matches the company’s named Dan Elenbaas card; last-confirmed parent governance is distinguished from an unpublished current full roster.

Former DreamWorks Interactive CEO and Electronic Arts technology/visual executive appointed Akili executive advisor in2017. Co-founded Pacific Data Images and worked with Vanedge Capital; current Akili advisory status is unverified.

Veteran game designer and former Google chief game designer appointed Akili executive advisor in2017. Earlier games experience includes Lucasfilm,3DO and DreamWorks; current advisory status is unverified.

Psychiatrist and eMindScience founder named to Akili’s clinical advisory committee in November2018. The source described an East Carolina University psychiatry affiliation; current committee service is unverified.

Former Cubist CEO and Biogen CNS commercial leader appointed Akili executive chair in2017. Founded Life Science Cares; later Akili board chairs are documented separately. Historical role only.

PureTech executive and Akili private-company director named as an existing director in its July2022 public-board nomination release. Nomination did not by itself establish a later public-company seat; that appointment remains unverified. PureTech’s primary announcements identify his CEO appointment April9,2024 and departure from CEO and board roles July16,2025. This is a historical PureTech affiliation; his existing Akili role and image are preserved. PureTech’s2022 annual-report biography subsequently confirms actual Akili director service November2017–September2019 and June2021–October2022, superseding the earlier nominee-only uncertainty. Exact appointment/resignation days are unpublished.

Social Capital founder and chairman of Akili’s public board following the2022 SPAC transaction. Akili’s October6,2023 leadership-transition letter confirms he left the board when Eddie Martucci became chair. Board membership does not establish an individual investment. Founder of Social Capital in 2011 and current CEO of its legal adviser The Social+Capital Partnership LLC, verified by March31,2026 ADV and the current own-site disclosures. He previously led growth and platform work at Facebook after roles at Mayfield, AOL and Winamp. His investment platform distinguishes historical external venture funds from proprietary permanent capital. His June29,2026 own 8090 announcement also confirms he became the AI software company’s CEO, a separate operating affiliation rather than a new manager cash raise.

Akili director associated with JAZZ Venture Partners, listed in the July2024 acquisition filing among all resigning public directors. Historical corporate governance is not an inferred personal cash check.

Named in Akili’s2022 public board and described as UnitedHealth Group’s former chief scientific officer. This is a historical confirmed board affiliation, not a current post-acquisition director assertion.

Published Akili vice president of marketing and communications with healthcare and consumer-marketing experience. Previously helped launch diagnostic technologies at PathAI and Foundation Medicine. Current post-acquisition employment is not established by the surviving company biography.

W. Edward (Eddie) Martucci II is an Akili co-founder who helped establish the company through PureTech in2011. Served as CEO until his October6,2023 transition to board chair; resigned from the board July2,2024 at the acquisition. Holds Providence College biochemistry and Yale molecular-biophysics/biochemistry degrees.

Akili director and audit-committee chair appointed October25,2022; resigned July2,2024 when Virtual Therapeutics acquired Akili. Earlier CFO experience includes PayPal, CBS Interactive and YapStone.

Appointed Akili chief marketing officer October7,2020, following women’s-health leadership at AMAG and marketing/customer-experience work at Boehringer Ingelheim. This is a dated historical appointment, not a verified current company role.

Appointed Akili chief financial officer in April2019. Previous finance leadership included Vertex Pharmaceuticals, Capgemini and Texas Instruments; graduate study at MIT/Sloan and the University of Massachusetts Amherst. Historical appointment retained, with current post-acquisition employment unverified.

William (BJ) Jones Jr served on Akili’s public-company board and resigned July2,2024 at the acquisition. Akili’s2022 biography identified his commercial leadership at Biohaven and earlier Takeda experience; outside-company titles are historical source descriptions.

Published Akili chief legal officer and general counsel, first appointed to its leadership in April2019. Earlier legal and compliance roles include IDEXX, Blue Health Intelligence, Allscripts and GE Healthcare; holds Purdue and Columbia Law degrees. Post-acquisition operating status is unverified.

Akili’s published chief product officer, appointed March17,2022. Earlier games-industry work included Glu Mobile, founding Taunt, PopCap/EA and Microsoft Xbox Live Arcade. Surviving company bio is qualified because post-acquisition operating status is unverified.

Clinical psychologist and published former-era Akili chief medical officer, appointed in2022 after leadership at Holmusk. Earlier spent more than twenty years at Duke and led ADHD research including Akili’s STARS trial. Studied clinical psychology at Auburn; website bio does not establish current post-acquisition employment.

Akili scientific co-founder and published chief scientific advisor, formerly an Akili director until July2,2024. UCSF Neuroscape founding director and cognitive-neuroscience researcher studying attention, memory, distraction and cognitive aging with neurophysiological methods. His Akili scientific biography remains publicly accessible; post-acquisition operating/advisory status is unverified.

Howdy Partners is a Durango-based early-stage venture firm established in 2018 as Greater Colorado Venture Fund (GCVF), which adopted its current name on September 10, 2025. The same team backs founders in rural and overlooked Colorado communities across AI, enterprise software, robotics, aerospace and agricultural technology. Its legal manager is Greater Colorado Ventures, LLC, identified in its March 12, 2026 Form ADV as an SEC exempt reporting adviser (CRD323465, file802-126968) with Howdy Partners as an additional trading name. Cory Finney and Marc Nager are founders and managing partners; Jamie Finney is a founder and venture partner, and Kiki Hooton leads community and events. Meritage Accounting Group supplies external fund administration and back-office services, rather than being an individual employee. The manager oversees separately documented Greater Colorado Venture Fund I and II limited partnerships: its own announcement confirms a USD17.5M Fund I raise in 2018 and a USD25M Fund II close announced January 25, 2023. Fund assets, LP commitments and cumulative portfolio deployments are distinct from closed fundraising. Primary issuer evidence confirms GCVF invested in AI infrastructure company Kamiwaza; its current portfolio also identifies space propulsion, autonomous farming, pediatric mental-health and cybersecurity companies. The original GCVF name is an alias of this firm, not a second investor.

Cory Finney co-founded Greater Colorado Venture Fund, now Howdy Partners, in 2018 and is a managing partner. A Durango-based entrepreneur, he previously co-founded and led SnowGate through acquisition, served as an entrepreneur-in-residence at Boomtown and co-founded Kokopelli Capital.

Jamie Finney is a founder and venture partner of Howdy Partners, focusing on investment and finance operations. His earlier work includes Startup Colorado and Kokopelli Capital. Based in Durango, he also writes about capital and equitable entrepreneurship.

Kiki Hooton runs community and events for Howdy Partners, including its Founders Summit and Pitch Series. Her background spans environmental technology and sustainability. She also serves as program and membership director at Local First in Southwest Colorado.

Marc Nager is a founder and managing partner of Howdy Partners. He co-founded and formerly led Startup Weekend and UP Global, then served as Techstars chief community officer and managing director of Telluride Venture Accelerator. He lives in Durango.

Matthew (Matt) Franklin was appointed Akili CEO in October2023 after joining as president and COO in2022. Earlier roles included Exact Sciences precision oncology, Thrive Earlier Detection, ArcherDX, Foundation Medicine and Boston Scientific; studied at Northwestern and Michigan. He is distinct from SoundBlade Medical’s chief financial officer Matt Franklin. Akili’s public board seat ended July2,2024; the surviving website bio is not proof of current post-acquisition executive employment.

Akili Interactive is the cognitive digital-medicine business founded in2011 through PureTech Health, with scientific and game-design founders including Eddie Martucci, Adam Gazzaley, Matthew Omernick and Adam Piper. Its Boston/San Francisco team developed neuroscience-based video-game treatments, including EndeavorRx and EndeavorOTC for attention difficulties associated with ADHD. Proprietary adaptive algorithms adjust sensory and motor challenges to engage attentional-control systems. It is relevant to neuroscience, adaptive software and digital therapeutics; the public sources do not establish a generative-AI model business. Regulatory and clinical efficacy claims are product- and population-specific, not a general treatment claim for every condition in its investigational pipeline. Akili Interactive Labs Inc became the operating subsidiary of public Akili Inc following its August19,2022 combination with Social Capital Suvretta Holdings Corp I. Virtual Therapeutics Corporation acquired Akili Inc on July2,2024 and took it private; the current parent website vthera.com continues to publish EndeavorRx/OTC. The0.434-dollar-per-share takeover price was acquisition consideration, not new financing. All seven public directors resigned at closing; Daniel J Elenbaas became sole director/president and Matt McIntire treasurer/secretary. Surviving executive bios and2017–2023 appointments are explicitly dated, with current post-acquisition operating status unverified; board resignations are recorded. No current private-company employee roster is publicly available. Primary venture announcements document30.5MSeriesB inJanuary2016,11.9MBextension inJuly2016,55MC inMay2018,13MCextension inAugust2018 and110MD equity inMay2021. The2021 headline160M includes an up-to50Mcreditfacility, not160Mequity. SEC disclosures separately establish actualSVBdraws5M inMay2021 and10M inJune2022, and a5MShionogi bond inMarch2019; facility ceilings and undrawn tranches are excluded from cash. The2022SPAC transaction generated162MactualPIPE and2.283Mtrust cash; the412Mforecast and1Bvaluation are not new actual proceeds. Shionogi licensing upfronts, future contingent milestones, royalty revenue and clinical partnerships are distinct from financing. EarlierSeriesAcapital remains unspecified where date/size is not verified.

Philip A. Starr is an external consultant to Echo Neurotechnologies, as disclosed in a2026 scientific publication, and a UCSF neurosurgeon specialising in movement disorders and implanted neurostimulation. He is a professor of neurological surgery and holds the Dolores Cakebread Chair. His research investigates motor-network physiology and adaptive deep brain stimulation using chronically implanted bidirectional interfaces. He earned his medical degree at Harvard, completed neurosurgery training at Brigham and Women’s Hospital and a movement-disorders fellowship at Emory. The consulting relationship is distinct from employment, board membership or an equity investment; academic and clinical grants are not Echo company cash.

Rico Severa is a senior accounting manager at Echo Neurotechnologies, confirmed by his own public appointment announcement. He describes specialist biotechnology accounting experience and full-cycle accounting work. His public education includes Chapman University, with data analytics and business studies, and his earlier experience includes BioMarin Pharmaceutical. His Google Data Analytics qualification supports his analytical finance background. The exact appointment day is not inferred from relative social-post timestamps.

Robert Gaffney publicly identifies a current professional affiliation with Echo Neurotechnologies in the San Francisco Bay Area. His own accessible profile also identifies Pepperdine University’s Graziadio School of Business and Management. The accessible first-party profile does not disclose his exact Echo position, so no chief executive, operations or director title is inferred. His affiliation is preserved as published without treating social reactions, unrelated namesakes or prior-company connections as evidence of new investment.

Sree N. Koneru is a medical technology professional who publicly announced joining Echo Neurotechnologies after his work at Viant Medical. He describes experience leading complex neurotechnology programmes from concept to clinical development and working at the intersection of engineering, neuroscience and clinically driven device development. His accessible public profile discusses a prior director of programme management role at Viant, but no equivalent current Echo executive title is inferred. Published work covers electroceuticals, RF fields and neuromodulation; prior products and approvals belong to their respective developers, not automatically Echo.

David A. Moses is a scientist working on neural decoding and speech neuroprostheses, and an assistant professor of neurological surgery at UCSF. A primary2025 Nature Neuroscience publication explicitly discloses that he is a director at Echo Neurotechnologies; it does not establish whether this is a board or functional executive title, so that capacity remains qualified. His research includes machine-learning methods that translate neural activity into communication for people with paralysis. UCSF identifies his doctoral work and subsequent postdoctoral research in Edward Chang’s laboratory. His academic research and patents do not independently establish corporate investment tickets.

Edward F. Chang is a co-founder of Echo Neurotechnologies, independently disclosed by UCSF and his published scientific work. He is a neurosurgeon and UCSF’s Joan and Sanford Weill Chair of Neurological Surgery, specialising in brain mapping, speech and motor preservation, epilepsy and implantable neurotechnology. His research examines neural mechanisms of speech, movement and emotion, and he co-directs the UCSF/UC Berkeley Center for Neural Engineering and Prostheses. He earned his medical degree and completed neurosurgery training at UCSF, following chemistry studies at Amherst. He was elected to the National Academies of Medicine and Sciences in2020 and2025. Academic research funding and experimental clinical results are distinct from Echo corporate financing and market approval.

Kenneth H. Louie is a neuroscience researcher and an employee of Echo Neurotechnologies, explicitly disclosed in his2026 Nature Medicine publication on adaptive deep brain stimulation for gait control in Parkinson’s disease. His earlier academic affiliations include biomedical engineering at the University of Minnesota and neurological surgery at UCSF. His research examines neural signals, gait and closed-loop neuromodulation. The published trial was completed before his Echo employment and states that Echo had no role in its design, data collection, analysis or publication. His exact current company title is undisclosed. He is distinct from similarly named Amazon product managers, dentists and economists.

Echo Neurotechnologies is a San Francisco brain–computer interface company developing hardware and AI systems intended to restore autonomy and communication for people living with neurological disabilities. Its current official recruiting materials describe an early-stage multidisciplinary engineering and AI organisation. UCSF identifies neurosurgeon Edward Chang as a co-founder; published scientific disclosures identify David A. Moses as a director, Kenneth H. Louie as an employee, and Philip Starr as an external consultant. Those research disclosures establish affiliations rather than a complete company roster or regulatory authorisation. In June2026 Intel announced exploratory collaboration with Echo on neuro-AI, speech neuroscience, brain–computer interfaces and neuromorphic/conventional computing architectures. That technology partnership is not treated as an equity investment. A&E Investments’ official portfolio links echo.bio and describes brain–machine interfaces that allow patients to control external devices. Its October2023 partnership entry establishes an investment relationship but does not disclose a financing close, stage or cash amount. No primary-verified priced round or FDA market clearance is asserted. Echo is distinct from Echo Health Ventures, Echo Labs, Echo cloud security and Echo Protocol.

Flowly is the operating brand of Tamadé Inc., a Los Angeles-area digital health company developing virtual pain and anxiety services, mobile biofeedback and immersive virtual reality relaxation experiences. Its current website offers a therapist-led fourteen-week Healing from Pain program for persistent nonstructural pain, combining one-on-one support, pain neuroscience education and on-demand exercises. Its separate VR wellness system pairs a smartphone app and headset with heart-rate feedback and guided breathing. Flowly distinguishes these wellness tools from a medical device and does not claim device regulatory approval. Its cited studies of pain reprocessing and other psychological therapies are distinguished from Flowly-specific clinical evidence: the NIH-supported VANISH study registered at NCT04236804 was a small, randomized, unblinded trial with twenty participants. Company marketing percentages and testimonials are not treated as universal clinical outcomes. Federal NIH records identify earlier operating entity Tamade LLC and two NIDA research awards totaling USD1,214,571; these non-dilutive awards are separate from equity backing and cumulative fundraising claims. Primary sources verify Y Combinator Summer2021 participation, True Wealth Ventures backing and additional accelerator and portfolio affiliations; transaction amounts and stages remain qualified where undisclosed. The public team includes three co-founders and named clinical staff; external physician testimonials, patients and unnamed first-name contributors are not automatically company employees.

Celine Tien is co-founder and CEO of Flowly. She leads its virtual pain and anxiety platform and is the contact principal investigator named in NIH’s R44DA049630 research award. Her background includes immersive filmmaking and work in animation development. Founder and clinical research roles do not imply a personal cash investment.

Julien Soros is co-founder and chief technology officer of Flowly. He studied electrical engineering at Yale with a focus on control systems and digital signal processing. His prior engineering work at Hyperloop One involved control algorithms and system stability analysis; earlier guitar-building experience informed his interest in engineering.

Lauren Flynn, PhD, is Flowly’s published lead therapist. The company describes her work in pain psychology, initial evaluations and matching patients with licensed therapists or pain coaches within its therapist-led program. Her authentic portrait appears on the company’s named lead-therapist page. Program outcome figures on that page are company claims, not independently established universal results. She is distinct from the professional football player with the same name.

Narae Kim is co-founder and chief creative officer of Flowly. Her professional work spans art and creative direction in virtual reality, film, theatre and entertainment, with projects presented at industry events and film festivals. She combines immersive content design with the company’s relaxation and biofeedback experiences.

Samantha Meadows, LCSW, is explicitly identified as a Flowly pain coach and licensed therapist in the company’s published articles on therapy and loneliness. She discusses therapeutic relationships, emotional resilience and the biopsychosocial dimensions of pain. The published affiliation is verified, but a complete current staff tenure and an authentic exact-person portrait remain unverified. Unrelated political candidates and other name matches are excluded.

Paul Kedrosky is published as a General Partner at SK Ventures and is a manager of its legal management company in the April28,2026 Florida annual report. He is an investor, entrepreneur and technology writer who founded HSBC James Capel’s technology-equity research practice. His published professional background includes research and commentary on entrepreneurship, innovation and venture finance at the Kauffman Foundation and Bloomberg. He trained in engineering, finance and the economics of technology. The manager biography contains historical career details; past professional appointments are not asserted as current employment, and personal angel investments remain separate from the firm’s portfolio.

Eric Norlin founded SK Ventures in May2011 and is published by the manager as a General Partner. He is also a technology-conference entrepreneur: his work includes Digital ID World, SaaScon, Defrag and Glue. Earlier he worked in identity-technology marketing at Ping Identity and contributed technology reporting and conference content. His manager biography describes a South Asian studies undergraduate degree and earlier government technology experience. The Florida management-company registry’s April28,2026 annual report identifies him as a manager. He publicly acknowledged SK Ventures’ investment in Kamiwaza on a company executive’s joining announcement; this is institutional evidence, not a separate personal check.

SK Ventures is a US seed-stage venture manager founded in May2011 by Eric Norlin and operated with Paul Kedrosky. It backs science-driven entrepreneurs with deep expertise in their domains and provides operating guidance, introductions and support for subsequent financing. Its published portfolio spans AI software, robotics, cybersecurity, developer infrastructure, climate and weather technology, earth observation and data platforms. Documented examples include Neurala, Skycatch, Amperon, Klue, Vouched, Virgo and enterprise-AI infrastructure company Kamiwaza. The live manager site publishes Eric Norlin and Paul Kedrosky as General Partners; its biographical career details and historical portfolio labels are preserved with source qualification rather than assumed updated acquisition statuses. The legal management company SK Ventures Management, LLC is a Delaware entity registered in Florida, document M12000005791, with a Siesta Key principal address and an April28,2026 annual report naming both managers. Individual LP and GP fund vehicles are separate from the manager brand. Kamiwaza’s own issuer announcement names SK Ventures, corroborated directly by Norlin acknowledging the investment; a media report naming SVK Capital is recorded as an unresolved attribution mismatch rather than used to merge the entities. This manager is distinct from UK SK Venture Partners, South Korean SK Group and unrelated manufacturing, property and offshore businesses with similar names.

Zaz Floreani joined FirstMile Ventures in summer2023 as Venture Partner and leads its Texas investing from Austin. She previously worked as Principal at Next Coast Ventures, building its pre-seed and seed investment platform, and held business-development and corporate-development roles at Mass Relevance, Spredfast and Dropoff. She holds graduate degrees from the University of Texas and a history degree from UCLA.

Aaron Stachel helped launch FirstMile Ventures with Bill Miller in 2014 and became a partner in its second fund. He invests across healthcare technology, robotics, logistics, fintech and other early-stage businesses. He previously served ten years as an Army officer and helicopter pilot, then worked in strategic finance and M&A at Newmont Mining. He studied economics at West Point and earned an MBA from Denver.

Bill Miller founded FirstMile Ventures in 2014 after operating and investing in technology companies. He co-founded StorageNetworks and served as CTO through its 2000 IPO; earlier ventures included CERAM and Krysalis. He also led enterprise-software companies XAware and Axellio. Before FirstMile he invested personally in technology startups. He studied chemistry at Illinois and began as a semiconductor process engineer, with patents in chips, memory and storage systems.

FirstMile Ventures is a Colorado-based pre-seed and seed venture-capital firm founded by Bill Miller in 2014 and legally identified as FirstMile Ventures, LLC in its SEC adviser filing (CRD311699). Its current public team includes founder and Managing Partner Bill Miller, Partner Aaron Stachel and Austin-based Venture Partner Zaz Floreani. The firm focuses on founders building technology companies in Colorado and Texas, offering direct partner support from the first institutional round through readiness for Series A. Its portfolio spans enterprise AI, cloud infrastructure, robotics, cybersecurity and healthcare technology, including Kamiwaza, BurstIQ and gut-brain care developer SideBy Care. The firm’s three flagship fund generations and five SEC-reported legal vehicles are distinguished from parallel Colorado Venture Capital Authority programmes. In 2026, Aaron Stachel publicly confirmed a $25 million close for Fund III; that aggregate commitment is not assigned in full to either individual 2024 legal vehicle, and asset values reported in FormADV are not fund closes. The firm has made more than seventy investments. Its earlier founder angel investments and fundraising by companies Bill previously led are distinct from FirstMile’s own fund sizes. The unrelated FirstMile logistics/shipping business and FPV Ventures are excluded.

Matthew Krna, also known as Matt Krna, is founder and Managing Partner of Ladera Venture Partners, a digital health-focused investment firm. His continuing role is named in current C1 Fund governance materials and public SEC filings. He is also founder and Managing Partner of Two Meter Capital and a Venture Partner at Alpha Partners. He previously co-founded and led Princeville Global and was a partner at SoftBank Princeville, with earlier investment roles at Investor Growth Capital and Canaan Partners and investment-banking experience at Credit Suisse and Donaldson, Lufkin & Jenrette. He has served as a director or board observer at companies including Doctor on Demand, Remitly, Criteo, Dotomi and ID Analytics, and previously served as CEO of Alpha Partners Technology Merger Corp. He holds an A.B. degree from Harvard University. These other-firm investments and funds are not automatically attributed to Ladera.

Ladera Venture Partners (LVP) is a Silicon Valley investment firm focused on the convergence of technology and health. Its issuer-published investment mandate is stage-agnostic and includes virtual care, mental health, fitness and wellness, and applications of data and artificial intelligence to healthcare. Public SEC filings identify the investment entity as Ladera Venture Partners, LLC and identify Matthew (Matt) Krna as founder and Managing Partner. His continuing Ladera leadership is corroborated by C1 Fund’s current public director biography and 2026 annual-report filing; his other roles at Two Meter Capital and Alpha Partners are distinct organizations. Akili Interactive explicitly names Ladera as a new participant in its USD110 million Series D equity financing announced on 26 May 2021, supporting prescription digital therapeutics for cognitive disorders. A separate USD50 million credit facility accounts for the broader USD160 million financing announcement and is not treated as Ladera’s equity investment. Krna also publicly identifies SWORD Health as a Ladera portfolio company, but the exact round, investment date and ticket are not established by that statement. Ladera’s own public website currently provides its brand and contact link without a full team directory, fund vehicles or fundraising announcements. No verified closed fund sizes, AUM, additional public staff or active fundraising claims are asserted; capital raised for Krna’s former Princeville and SoftBank-affiliated firms is not attributed to Ladera.

Physician and healthcare investor promotedtoPartnerandEvidityManagementCommittee inownJuly5,2023release,afteroverseeinginvestment sourcingandevaluation. PriorMcKinseyhealthcareconsultant,UniversityofPennsylvaniaemergencymedicineinternship,GoldmanSachsinvestmentbankanalyst andHarvardMedicalSchoolhealthcarepolicyresearchassistant. Own2019rebrandreleasecalledhimPrincipal. Heisabsentcurrentpublishedteambio and2026foundertransitionmessage thanks himforbuildingEvidityoverthepast11years; roleisexplicitlyhistorical,exactdeparturedayunknown. Genuineownnamed2022portraitretrievedfrompublicWordPressattachmentrecord,notclaimedfresh2026photo.

JoinedEvidity in2021 accordingtoownbio; alternativeasset accounting/financeprofessional withnearlythreedecades experience andpreviousCFO roles attwolife-sciences/technologyVC firms2008–2019,plushedgefundandmultistrategyplatformfinance. Begancareerasa BDOfinancialservicesauditmanager; QueensCollegeBAAccountingandEconomics,CPAandCFA. OwncurrentEviditydirectorylistsCFO; exactjoiningdayunknown. No personalportfolioinvestment or inferredEckuityrole.

Co-founded CanepaHealthcare/Evidity withPaulEnever in2014. Former McKinseyPartner in telecommunications,mediaandtechnology; prior HermesGrowthPartners cofounder wherehelaunchedtheTMTfund. Systemsengineer withStanfordMS inEngineering-EconomicSystems. OwnEviditybiography listsPoseidonMedical/PreludeDx boards andformerAkiliobserver,Biotheranostics,DuneMedical,EndoGastricSolutions affiliations. His own2026 announcement saysEviditybecomingpartofEckuity andheandPauljoining; currentEckuityteamlists himasPartner. Historicalmanagerchecksremaininstitutionalattribution,notpersonal. Alejandro Sanchez is partner at Eckuity Capital. Co-founded Evidity in 2014 and joined Eckuity as a partner in 2026. Historical Evidity and Canepa investments retain their original institutional attribution.

Stevie Case is published in Coalition Operators’ external operator network. Revenue exec trusted by top startups to turn trust and security into growth. Published career affiliations: Vanta, Twilio. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company. Stevie Case is a published general partner of 20SALES, focused on smb through enterprise, outbound, cs, marketing. The official fund directory highlights operating experience associated with vanta, Visa, Twilio. These career references describe expertise rather than additional inferred current employment.

Shani Taylor is published in Coalition Operators’ external operator network. Go-to-market force behind the tools redefining how teams design and build together. Published career affiliations: Figma, Airtable. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Co-founded the CanepaHealthcare/Evidity investment firm with AlejandroSanchez in2014. Former McKinseyPartner with twelveyears advising biopharma,medtech,hospitals andhealthcareservices; earlier SandozR&D andMITbiotechnologyresearch. Holds a Rensselaer chemicalengineeringBS and UniversityofMinnesota chemicalengineeringPhD focusedonwoundhealing/tissueengineering. OwnEviditybio lists Augmedics,MagnoliaMedical andPoseidonMedical boards and formerCardiva,DuneMedical andStandardMolecular boards; no uncoordinatednew outsidecompanyroles orpersonalchecks are inferred. Current2026Eckuitydirectory independentlylists himasPartner and foundertransitionpostexplicitlydescribes joiningEckuity; legacyEvidityrole notexclusivecurrentoperatingclaim. Paul Enever is partner at Eckuity Capital. Co-founded Evidity in 2014 and joined Eckuity as a partner in 2026. His existing Evidity biography, portrait and institutional affiliations are preserved.

Rachel Hepworth is published in Coalition Operators’ external operator network. Brand and growth marketer behind the most iconic B2B platforms of our time. Published career affiliations: Notion, Slack, LinkedIn. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Evidity Health Capital is the healthcare venture and growth-equity investment brand of Evidity Capital LLC, formerly Canepa Healthcare LLC. Its March20,2026 FormADV (CRD288126, SEC802-110483) lists Canepa Healthcare and Evidity Health Capital as business names of the same adviser. The firm’s own December10,2019 release explicitly announced a name change with the same investment team and focus, rather than an unrelated new fund manager. It was founded by Paul Enever and Alejandro Sanchez in2014 and invests in medical devices, in-vitro diagnostics and digital health, generally focusing on commercialized products needing growth capital to reach profitability. Published neurotechnology exposure includes Akili’s clinically validated cognitive digital therapeutics, Sonde Health’s investigational vocal biomarkers for brain and psychological health, and GT Medical Technologies’ GammaTile localized brain-tumor radiation technology. These portfolio technologies have distinct research and regulatory states; a portfolio description does not grant blanket clinical validation. Its own directory publishes Paul Enever and Alejandro Sanchez as partners and Lloyd Appel as CFO, while the own July2023 appointment release documents Adam Lessler’s partner and management-committee promotion. Adam is absent from the current biography directory and receives an explicitly historical role. Important current2026 transition: Alejandro’s own announcement says Evidity is becoming part of Eckuity Capital and that he and Paul are joining Eckuity; Eckuity’s own current team independently lists both as partners. Their historical Evidity affiliation and original portfolio buyers remain preserved; this does not make Eckuity the buyer of old Canepa or Evidity checks, nor establish a silent legal dissolution or transfer of every fund. The separate actual legal vehicles reported in the March2026ADV are Bermuda Canepa Advanced Healthcare Fund LP, with Canepa Advanced Healthcare Partners Ltd as GP, and Delaware Evidity Advanced Healthcare FundII LP, with Evidity Advanced Healthcare FundII GP LLC. Fund gross assets, commitments targets, minimum tickets and company financing totals are not finalclosedfundsizes. Actual final-close cash and exact closingdays were not publicly established and remain unknown. Akili securities disclosures identify FriggaLtd as a holdingvehicle beneath CanepaAdvancedHealthcareFundLP advised by EvidityCapitalLLC; historic manager-managed exposure is sourcequalified instead of mistaking a fund or holdingvehicle for a renamed corporate manager.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as CVP of Microsoft Cloud and AI, and Distinguished Engineer. These external titles are source-qualified directory context, not additional unverified employer roles.

Poppy Thorpe is published in Coalition Operators’ external operator network. Brand visionary for the companies shaping categories and culture. Published career affiliations: Glossier, Snap. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Washington Research Foundation Entrepreneurship Endowed Professor in the Paul G. Allen School of Computer Science and Department of Engineering Electrical & Computer, and Head of Health Technologies at Google. These external titles are source-qualified directory context, not additional unverified employer roles.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Professor, and Bill & Melinda Gates Chair Emeritus, UW Paul G. Allen School of Computer Science & Engineering. These external titles are source-qualified directory context, not additional unverified employer roles.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Co-founder, board director, and former CEO / CTO of ExtraHop. These external titles are source-qualified directory context, not additional unverified employer roles.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Founder of Kubernetes, and Founder & Former CTO of Heptio (acquired by VMware). These external titles are source-qualified directory context, not additional unverified employer roles.

Maggie Hott is published in Coalition Operators’ external operator network. Sales leader for the defining technologies of the AI and no-code eras. Published career affiliations: OpenAI, Webflow, Slack. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company. Maggie Hott is a published general partner of 20SALES, focused on plg, mid market, enterprise, solutions engineers, sales dev. The official fund directory highlights operating experience associated with Webflow, Open AI, Slack. These career references describe expertise rather than additional inferred current employment.

Melynda Barnes is published in Coalition Operators’ external operator network. Physician and startup executive passionate about building groundbreaking patient-first experiences Published career affiliations: Ro, Weill Cornell Medicine, Yale Medicine. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as CEO of AI2 (Allen Institute for Artificial Intelligence) and Professor UW Paul G. Allen School of Computer Science & Engineering. These external titles are source-qualified directory context, not additional unverified employer roles.

Member of Pioneer Square Labs’ current Technical Advisory Board. The PSL directory describes this person as Former CVP of Microsoft Azure Cloud Security & Microsoft for Startups. These external titles are source-qualified directory context, not additional unverified employer roles.

Kate Earle Jensen is published in Coalition Operators’ external operator network. Enterprise sales leader at the cutting edge of AI and financial infrastructure. Published career affiliations: Anthropic, Stripe, Google. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Caleb John works in engineering at PSL. His biography describes founding Cedar Robotics, working on AI infrastructure at Anduril and founding Pongo, a search-model infrastructure business acquired in2024. He briefly attended the University of Washington.

Gail Airasian is published in Coalition Operators’ external operator network. Operator who’s driven impact across the most innovative companies in healthcare IT. Published career affiliations: Codametrix, Flatiron Health, anthenahealth. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Heather Fernandez is published in Coalition Operators’ external operator network. Operator-turned-founder with a track record of building trust-driven software and marketplaces at scale. Published career affiliations: Solv, Atlassian, Trulia. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Malaika Brown is an executive assistant in PSL’s current directory. Her biography describes prior community-development work at the YMCA and six years as a recruiting coordination manager at Facebook. She supports people and operational relationships at PSL.

Alex Ray is a PSL principal supporting existing companies and creating new ones with Greg Gottesman. His biography describes prior McKinsey business-building work, two startup founding experiences and venture experience at Oxbow Ventures. He works on accessible applications of frontier technologies including generative AI.

Caitlin Sowers is a product design engineer at PSL. Her biography describes joining in2025 after working on a visual AI workflow development platform at Salt AI. She works with founders and engineers on early-stage products.

Andrea Leach works in administration at PSL, joining in2021. Her biography describes office-management and administrative-support responsibilities and prior work at Pike13. She studied at the University of Washington.

Annie Pearl is published in Coalition Operators’ external operator network. Product leader who has scaled iconic SaaS and AI platforms from early traction to mass adoption. Published career affiliations: Microsoft, Calendly, Glassdoor, Box. Network membership is distinct from a firm employee or general partner role; listed career affiliations do not establish current employment at every named company.

Matt Wang is a principal in PSL’s current directory. His biography describes joining in2021 and earlier project-lead/chief-of-staff responsibilities supporting Greg Gottesman. He previously worked at Boston Consulting Group, DoorDash and Innosight and studied philosophy at the University of Chicago.

Ben Gilbert is a PSL venture partner and co-founder/co-host of Acquired. His biography describes prior independent software development and Microsoft product work, including Office for iPad and The Garage. He studied computer science and engineering at Ohio State.

Geoff Entress is listed as a venture partner on the current PSL directory. His biography retains the earlier managing-director/co-founder wording; the official2026 adviser filing separately identifies him as managing director/member of Pioneer Square Investment Advisor. Those unit-specific roles are retained with sources rather than assuming identical titles across the studio and fund.

Jaclyn Rice Nelson is co-founder and part-time gp at Coalition Operators. Jaclyn is the co-founder and CEO of Tribe AI, a startup powering the enterprise AI wave. Jaclyn has a multi-faceted view of the AI platform shift: the build versus buy decisions of her enterprise customers, the speed of innovation at the top AI platforms Tribe builds on; and the interests of Tribe’s network of 600+ top AI engineers. In addition to backing AI startups at Coalition, she helps founders across categories think through how to leverage AI to build better products, power their companies, and rethink team building. Outside company titles are attributed to the firm’s published biography, not automatically changed on external organizations.

Lindsay Ullman is co-founder and part-time gp at Coalition Operators. Lindsay has built and backed companies from every angle—as a founder, investor, buyer, incubator, and product leader. She started Umbrella, a community marketplace for seniors (acquired by IAC), and now leads product for Angi. Before that, she was a partner at GV and a company builder at Sidewalk Labs. Lindsay is the ultimate dealmaker and negotiator. She works closely with Coalition founders on fundraising, product strategy, and loves nothing more than helping them puzzle through a tough business decision. Outside company titles are attributed to the firm’s published biography, not automatically changed on external organizations.

T.A. McCann is a current PSL venture partner and technology entrepreneur. His biography describes founding Senosis, Gist and Rival IQ, earlier work at Microsoft and entrepreneurial roles at Polaris, Vulcan and Providence Health Services. Published angel-investing references are not automatically attributed as PSL fund investments.

Ashley Mayer is co-founder and full-time gp at Coalition Operators. Ashley is our full-time leader at Coalition. Her first career chapter was in communications, where she helped visionary founders craft stories that shaped their companies’ trajectories. She led comms at Box from early days through IPO, was the first marketing partner at Social Capital, and helped scale Glossier from a cult beauty brand to a household name. Building a startup is all about crafting and selling a story about what the future should be. Ashley backs founders across categories, and partners with them to make sure their stories reach and resonate with their most important audiences. Outside company titles are attributed to the firm’s published biography, not automatically changed on external organizations.

Julie Sandler is a current PSL venture partner and co-founder of PSL Ventures. Her biography describes her earlier tenure as general partner/managing director and prior work at Madrona. She focuses on early-stage Pacific Northwest technology companies; her historical leadership title is distinct from her current venture-partner role.

David Zager is a partner at Pioneer Square Labs, leading product, visual and business design since its2015 founding. His biography describes supporting studio concepts and portfolio companies, with board responsibilities at Dance Church and Official AI. He studied visual communication at the University of Washington.

Palvi Mehta leads finance and operations as PSL’s operating partner and CFO. She previously served as CFO at ExtraHop, NewPath Networks and RadioFrame Networks and began her career at Ernst & Young. The official2026 adviser filing identifies her as CFO of Pioneer Square Investment Advisor.

Greg Gottesman is a co-founder and managing director of Pioneer Square Labs. He previously spent20 years as a managing director at Madrona and co-founded Rover. His published PSL biography describes current investment and board responsibilities and teaching entrepreneurship at the University of Washington.

PSL Ventures is the venture capital investment unit associated with Pioneer Square Labs in Seattle. The official2026 FormADV identifies its legal adviser as Pioneer Square Investment Advisor, LLC, CRD292854, and lists Pioneer Square Ventures FundI and FundII as managed private funds. PSL Ventures targets early technology companies primarily in Washington, Oregon, Idaho and British Columbia, including AI-enabled software, cybersecurity, infrastructure and digital health. It leads or co-leads external pre-seed, seed and SeriesA rounds and also invests alongside outside leads in studio spinouts. The official FAQ identifies PSL Ventures and PSL Studio as separate entities/operations with overlapping leadership and support teams; the broad PSL studio investor4694 and its historical links are retained separately. The published PSL directory supplies14 shared operational/investment people; unit-specific legal/current roles are source-qualified. FundII was announced as an oversubscribed USD100M vehicle inMarch2021; the historical FundI was reported as USD80M. The studio’s2023USD20M company-creation capital and combined Ventures180M management figure are not additional investment funds or portfolio checks.

FOV Ventures is a European venture capital firm backing early-stage companies in robotics, physical AI and spatial computing. It invests in the infrastructure and tools that connect digital systems with the physical world, as well as industrial and consumer applications. Operating from Helsinki, London and Paris, the firm typically invests EUR 100,000–1 million initially, can lead pre-seed rounds or participate at seed, and reserves capital for follow-on financing. Its partners support founders with specialist computing expertise, customer and investor introductions, and the EDGE network of experienced operators and technical experts.

Stephen Industries is a Finnish single-family office and investment company owned by entrepreneur Kustaa Poutiainen’s family. It backs health technology, deep technology and environmental technology businesses in Finland and Europe, including medical devices, therapeutics, advanced materials, semiconductors and clean energy. The firm typically invests EUR 100,000–3 million in startups from pre-seed through Series B and EUR 2–15 million in growth and buyout opportunities. It combines long-term ownership with strategic, operational and fundraising support and also invests in private-market funds. Previously an industrial holding company, it expanded its investment activity following the sale of atomic-layer-deposition company Picosun to Applied Materials in 2022.

Former investor at HTC Vive X and Seedcamp, and an early SoundCloud team member.

Former Google and Netflix executive and founder of augmented-reality platform Poplar.

Background in finance, investment banking, management consulting and private equity; evaluates investment opportunities.

Finance executive who became deputy CEO in 2021 and CEO in spring 2026, after serving on subsidiary boards.

Serial entrepreneur who built Picosun into an international atomic-layer-deposition business before transforming Stephen Industries into a single-family office.

Experienced in administrative support, cultural management and event coordination.

Supports investment sourcing and financial modelling, with experience in banking, mergers and acquisitions and investing.

Previously led Nordic XR Startups and worked on Finland’s XR ecosystem at Business Finland.

Experienced in international finance, investment banking, company evaluation and board service.

Founded MelloVR and later worked at the investor CRM company Höpöhöpo.

Reviews investments and supports portfolio companies with strategic planning and fundraising; background in corporate finance.

Alexandra Prieux is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Director of Development for Alcen. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Ariane Galaup Paci is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Supervisory Board Executive Committee Chairwoman, Director for Research, Leem. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Aviv Shoher is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Supervisory Board Finance, Audit & Risk Committee Chairman, Managing Partner, IMed Capital. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Jorge Pimenta is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Innovation Director, IPN – Instituto Pedro Nunes. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Julia Schaft is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Managing Director at BioRN. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Lucas Scherdel is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Managing Director, DayOne. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Yolanda Puiggrós Jiménez de Anta is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Partner at PwC Tax & Legal Spain. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Alexandra Celani-Betz is listed by EIT Health as Director of Finance and Risk. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

Ali Neary is listed by EIT Health as Director of Communications and Corporate Affairs. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

Chad Floe is listed on EIT Health’s supervisory board. The institution’s directory describes this person as Chairman of the Supervisory Board, Senior Advisor at TVM Capital Healthcare and deNovo Corporate Advisors. This governance affiliation is separate from the external professional position listed alongside it; exact appointment dates are not stated.

Séverine Lacharme is listed by EIT Health as Operations Director. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

EIT Health is a European nonprofit healthcare innovation network legally identified as EIT Health e.V., based in Munich. It connects healthcare, research, education and business partners and supports medical technology, life sciences, digital health, data-driven innovation and healthy ageing through strategic funding, startup programmes, education and commercialization support. Its funding includes European Union support through the European Institute of Innovation and Technology, member contributions, regional and national funding and selected commercial activity reinvested in its mission. Its published governance comprises five management-board members and eight supervisory-board members; supervisory members’ outside employers are professional affiliations, not EIT Health employees. The 2020 Start-up Rescue Instrument awarded EUR5.5 million across eleven named startups through co-investment grants in return for options. MRIguidance is explicitly among the recipients. This funding mechanism is distinguished from ordinary priced venture equity, mentoring and programme participation. Individual award and disbursement amounts are not inferred from aggregate totals or maximum awards. The parent European Institute of Innovation and Technology is a separate institution; EIT Health is not represented as a private venture fund.

Céline Carrera is listed by EIT Health as Interim CEO and Director of Programmes & Delivery. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

Graham Armitage is listed by EIT Health as Director of Community and Stakeholder Engagement. EIT Health’s governance disclosure places the management board in charge of day-to-day operations and strategic leadership. Exact appointment dates and a detailed individual career biography are not published on this directory.

Applied Cognition Inc. is a private neuroscience and biomedical technology company in Redwood City, California developing noninvasive measurement of human glymphatic function and investigational treatments directed at brain waste clearance. Its sensor and research platform measures physiological features associated with sleep-active clearance of amyloid beta, tau and other metabolites. The company combines biomedical engineering, neuroscience, clinical research, algorithms and data science; its published mission includes building a dataset for future AI integration in therapeutic discovery. Its pipeline includes investigational ACX-02 and exploratory ACX-14 programs targeting glymphatic mechanisms relevant to Alzheimer’s disease, Parkinson’s disease and post-traumatic headache. Peer-reviewed human studies and a March 2026 preprint report physiological and biomarker findings; these are not proof of disease prevention or regulatory approval. The current public leadership directory names co-founders Paul Dagum and Jake Winebaum. Additional research affiliations are qualified against dated scientific publications. Primary investor portfolios verify backing from GreyMatter Capital, Mayfield, What If Ventures, Supermoon Capital and A&E Investments; exact company cash financing amounts, stages and closing dates remain undisclosed in reviewed primary sources. An MTEC technology showcase also confirms a government-sponsored research award, with its amount, award date and precise legal sponsor unverified.

Alejandro Corbellini, PhD, is a computer scientist and systems engineer whose professional profile names Applied Cognition. The January 2026 Nature Communications paper and March 2026 preprint explicitly identify his Applied Cognition affiliation. He studied computer science at UNICEN and has worked on distributed systems, recommendation algorithms and graph processing. His authentic portrait comes from his named former-personnel entry at UNICEN’s ISISTAN; that archival image is low resolution and is not represented as a newly taken photograph.

Jake Winebaum is chairman and co-founder of Applied Cognition. The current company roster publishes his leadership role, and the company’s 2025 Nature Biomedical Engineering paper identifies him as Jake J. Winebaum with an Applied Cognition affiliation. Earlier company scientific presentations also use Jacob Winebaum. His research coauthorship concerns noninvasive measurement of human glymphatic function; publication authorship and employee shareholdings are not treated as a personal cash investment.

Laurent Giovangrandi, PhD, is an Applied Cognition scientist and engineer working on biomedical devices, algorithms and measurement of human glymphatic function. PhysioWave’s own leadership biography names him as its co-founder and as Senior Principal Scientist/Engineer at Applied Cognition, with earlier work at Triple Ring Technologies, Stanford and Malibu IQ. Applied Cognition affiliations are independently published in its 2025 and 2026 scientific papers. The portrait is PhysioWave’s authentic named photograph.

Paul Dagum, MD, PhD, is co-founder and CEO of Applied Cognition and an entrepreneur, physician and computer scientist. He invented the company’s investigational device for noninvasive measurement of human glymphatic function and leads its work on brain clearance and neurological therapeutics. Previously he founded Mindstrong to develop digital biomarkers of cognition and mental healthcare. His American Academy of Arts and Sciences biography describes earlier venture-backed work across healthcare, cybersecurity and supply chains.

Tarandeep Singh is a research author explicitly affiliated with Applied Cognition Inc. in the company’s May 2025 Nature Biomedical Engineering and January 2026 Nature Communications papers. The 2025 author contribution statement credits him with data collection and management, formal analysis and experimental research. The publication affiliation is verified; a current formal employment title and an authentic portrait have not been independently established. Unrelated people with the same name are excluded.

Andrew Tan is a technology investor who publicly describes his affiliation as VC at A&E Investments and co-founder at Hi Labs. His own LinkedIn profile identifies Carnegie Mellon University and a separate current affiliation with Salience Capital. In his public Nace AI announcement he identifies himself and Lip-Bu Tan as early investors through Salience Capital and A&E Investments. Exact A&E executive title and appointment date are not publicly confirmed in the accessible first-party biography. He is distinct from the Berkeley/Stanford-trained Andrew Tan associated with Tower Research Ventures and the separate Signal profile andrew-tan_1.

A&E Investments is a San Francisco technology investment platform associated with A&E Investment LLC. Its official portfolio spans artificial intelligence, enterprise software, semiconductors, computing infrastructure, life sciences and neuroscience, from early-stage companies to public-market businesses. Published investments include Applied Cognition, Echo Neurotechnologies, LVIS, Together AI, Insitro, Corintis, PsiQuantum and IonQ. The operator’s privacy policy names A&E Investment, LLC. A primary SEC filing identifies Lip-Bu Tan as manager of A&E Investment LLC, owned by his family trust; his personal holdings and separate Celesta/Walden investment vehicles are distinct. Andrew Tan publicly identifies himself as an A&E venture investor and separately appears at Salience Capital. The firm’s public team page requires membership, so its full private roster and current executive titles are not asserted. Portfolio partnership dates describe relationships and are not presumed to be financing closing dates. No publicly verified external LP fund close, size or AUM is asserted.

Startup communications and marketing professional, formerly with How to Web and Pago.

Product leader experienced in developing SaaS and digital products across international markets.

Operations professional formerly with Seedblink, ANIS Romania and Gecad Ventures.

AI entrepreneur whose startup MorphL was acquired by Algolia in 2021.

Technology recruitment specialist and founder of an HR consultancy.

Media and communications professional with experience in journalism and startup content strategy.

Founder of 7card, later sold to Sodexo; invests across multiple industries.

Startup investment professional with prior Renderro business-development and Techstars community experience.

Former EY professional whose software company provides startup CFO services.

Systems-engineering graduate, Romanian Space Initiative member and student pilot.

Former UiPath Head of Growth with experience scaling enterprise software marketing.

Sherbrooke, Quebec venture capital firm investing at pre-seed and seed in quantum computing, sensing, communications and the technologies that enable them. It helps research-led startups commercialize scientific advances, including quantum hardware and software, imaging, materials and low-power AI processors, and supports Quebec companies and international businesses building operations in Quebec.

Bucharest-based venture capital firm backing early-stage Eastern European founders building businesses for global markets. Its focus includes enterprise AI and automation, industrial technology, cybersecurity, defense and space technology. It combines investment capital with hands-on support in product strategy, hiring, communications, growth and financial operations. The manager is Underline Ventures B.V., registered in the Netherlands.

Venture investor and How to Web founder; previously founded Conectoo.

Engineering-physics specialist in quantum chemistry and nanomaterials; previously commercialized deep technology at Anyon Systems.

Venture and finance professional, formerly at Relay Ventures and CFO of Tools For Brokers.

Finance and business-strategy professional, ACET CEO since 2017, and prior manager of ACET Capital funds.

Quantum-computing PhD with prior outreach leadership at Waterloo IQC and quantum-safe cybersecurity product experience at ISARA.

Named Health Innovation FundI supervisory-board member representing Achmea in the manager’s own public roster. Achmea’s original July2021 fund-introduction presentation names her FundManager and includes the authentic individually labeled portrait. This photograph and outside title are historical2021 source material, not an assertion of current2026 Achmea operating status. The current legacy-fund roster remains directly evidenced.

Named Health Innovation FundII supervisory-board member representing VGZ in the manager’s own roster. VGZ’s May22,2026 own interview identifies her as DirectorZorgOperationsAdviesControle and discusses responsible AI use inside the insurer; its individually named originalportrait is used. These institutionalroles do not create a personal ventureinvestment.

Named supervisory-board member of Health Innovation FundsI andII, with Mediq shown as the representing institution in Health Innovations’ own published roster. The public roster does not supply joining/end dates or a current personal biography. This fund affiliation is source-qualified; outside current same-name roles are not silently used to refresh the historical Mediq affiliation. No authentic individually named photo was verified; the current Dutchmed named card uses a generic user-placeholder and is deliberately not imported.

Named supervisory-board member of Health Innovation FundsI andII representing ABNAmro in the manager’s own public roster. ABNAmro’s own current healthcare-sector page independently names him and publishes his individual portrait. Fund-supervisory roles are separately scoped and not manager statutoryboard appointments.

Named Health Innovation FundIII advisory-board member in the Health Innovations own public roster. The firm does not identify an outside employer in that roster; additional same-name biographies and portraits are not attached without independent identity confirmation. No personal investment is inferred.

Named Health Innovation FundIII advisory-board member representing OostNL in the manager’s own public roster. OostNL publishes an individually named employee biography and authenticportrait. This source does not establish an exact joiningdate or personalportfolioinvestment.

Named Health Innovation FundIII advisory-board member representing Menzis in the original Dutch own roster and his own professional profile. The firm’s English translation instead says OostNL; this conflicting translation is retained as a source qualification and the Dutch original is used. No unauthenticatedportrait or personal check is inferred.

Named Health Innovation FundIII advisory-board member representing KPNVentures in the manager’s own public Dutch roster. KPNVentures current own team calls him ManagingDirector; older2022 notices called him InvestmentDirector. This is a fund advisory appointment, not a manager statutory-directorship or personalcheck.

Healthcare investor at Health Innovations since2012 according to the own biography. Former PwC consultant and ABNAmro healthcare sector director; own public profile describes his lead work on Nightbalance, ViCentra, Aidence and Prolira. Joiningyear is known but exact day is not.

Health Innovations is a Dutch healthcare venture investment manager based in Utrecht, legally identified by the Netherlands Enterprise Agency (RVO) as Health Innovations B.V. Its own company profile dates the investment brand to 2007 and its first Health Innovation fund began that year; this is investment-history dating, not a separately verified incorporation date for the management corporation. It backed innovative healthcare businesses between 2007 and 2023 in digital health, healthcare services and health technology, with prevention, diagnosis, treatment and monitoring as practical applications. Its current own website explicitly says it continues to support existing portfolio companies and has no active fund for new investments. RVO also classifies its three Seed Capital vehicles as outside their investment periods and eligible for follow-on investments only. Published portfolio relevance includes MRIguidance MRI-derived bone imaging, Aiosyn digital pathology, STIL tremor technology and former holding LivAssured epilepsy monitoring; the own exit account explicitly describes Aidence as AI software for lung cancer detection on CT scans. The public directory names two operating investors and eight distinct fund advisers/supervisors, including separate fund-I and fund-II supervisory appointments; these fund governance roles are not inferred statutory directors of the manager. Dick Sietses remains on this own roster but is also explicitly a Capricorn Healthtech Fund II team member in January 2025, so his legacy portfolio affiliation is distinguished from an exclusive current full-time operating claim. Health Innovation Fund I B.V. and II B.V. each have an RVO-reported EUR8M investment budget including a EUR4M government loan. Health Innovation Seed Fund III B.V. has a EUR12M Seed Capital investment budget including EUR6M EZK/VWS loan; the original 2018 Fund III launch separately describes a broader EUR15M planned investment budget. These public-program budgets and allocations are preserved as such and not treated as verified private LP final closes or additional company financing. Legal fund vehicles are recorded with unknown final-close cash and exact closing dates. The manager is distinct from the similarly named HI-NL clinical innovation platform and unrelated international healthcare funds.

Rob Goulding is an Operating Partner at Moxxie Ventures who leads go-to-market support for its portfolio. Earlier he built mid-market sales and revenue organizations at Google and Twitter and served as a startup chief revenue officer. He helps founders identify customers, improve positioning and develop repeatable sales processes and early commercial infrastructure. His published manager biography describes these operating experiences rather than personal investment participation.

Prateek Joshi is an investor at Moxxie Ventures, which announced his appointment on April17,2023. He is an AI engineer, founder and author of thirteen books on artificial intelligence and machine learning. Previously he founded Plutoshift and worked on machine-learning products at Nvidia. His work spans computer vision, industrial automation and mobile software. At Moxxie he supports founders developing AI products and infrastructure. He hosts the Infinite Curiosity podcast and publishes writing about AI and startups.

Marie Drez is Moxxie Ventures’ Chief Financial Officer. Her published manager biography describes more than twenty years working with venture funds, including Magnify Ventures and Crosscut Ventures. She supports emerging managers with fund formation and closing processes, strategic budgets, capital tables, financial operations and automation, and advises new and aspiring general partners. These former-firm affiliations provide professional background without asserting current employment there.

Alex Roetter is a General Partner at Moxxie Ventures. An engineer and operator, he previously served as Twitter’s Senior Vice President of Engineering and led its advertising engineering organization. He later ran Kittyhawk Flyer, an electric aviation company, and worked as a test pilot. He joined Moxxie as an equal general partner in2021 and assists portfolio founders with engineering, product development, operations and cash management. His personal advising and angel-investing experience predates the firm; no personal checks are inferred as manager investments.

Katie Jacobs Stanton founded Moxxie Ventures in2019 and is its General Partner. She previously led product, marketing and market-development teams at Twitter, Google, Yahoo and Color, and served in the Obama White House and US State Department. At Moxxie she supports founders with go-to-market strategy, brand development, communications and team building. Her published manager biography describes board service at Yahoo and Vivendi and a substantial personal angel-investing history; those earlier personal investments are not automatically attributed to Moxxie. She is distinct from Katie Stanton, the finance-and-operations executive at S2G Investments.

Moxxie Ventures is an operator-led venture firm founded in 2019 by Katie Jacobs Stanton. It invests primarily at pre-seed and seed in North American companies building software and systems, including vertical AI, healthcare, infrastructure, robotics, climate technology, enterprise software, fintech and consumer products. Its current published criteria favor a technical founder and evidence of a product, and its typical stated check range is USD500,000–2 million; those criteria do not establish any individual investment ticket. Its clinical-AI portfolio includes Knit Health, alongside companies applying AI to health-system operations, pathology, dermatology and clinical research. General partners Katie Jacobs Stanton and Alex Roetter draw on product, engineering and operating experience at Twitter, Google and other technology companies. The manager announced the actual USD85 million Fund II close in July2021 and USD95 million Fund III close in July2024. The legal adviser Moxxie Management, LLC is an exempt reporting adviser, CRD315493; its March18,2026 Form ADV lists Boulder, Colorado as its principal office. Legal fund assets and targets are distinguished from closed fundraising. Current publicly named people and genuine manager portraits are documented separately from founders’ personal angel investments.

Vivek Ladsariya is Managing Director at Pioneer Square Labs and General Partner of PSL Ventures. His prior investing experience includes SineWave Ventures and Fenox; he holds engineering and MBA degrees from Mumbai and Yale. Kamiwaza’s January2025 SEC filing names him as a director, although a current complete issuer board roster is not published.

Daniel Davenport joined Kamiwaza as Federal Field Chief Technology Officer in the August2026 leadership announcement. He brings more than two decades of experience in defense, intelligence and space technology, most recently as SAIC Deputy Chief Engineer. His issuer-linked profile is linkedin.com/in/davenportdaniel.

James Urquhart joined Kamiwaza as Field CTO and Technology Evangelist in 2025. His current public self-profile states that he recently left the company following a strategy change; the exact departure day is not disclosed, so this is a former affiliation. His prior work includes VMware, Dell, Cisco and AWS, and he authored Flow Architectures.

John Drake joined Kamiwaza as Chief Revenue Officer in the company’s August2026 leadership announcement. He previously led go-to-market strategy for major Amazon Web Services storage portfolios and spent more than a decade at Faction.

Joseph Infantino joined Kamiwaza as Vice President of Operations and Finance in the August2026 leadership announcement. He previously co-founded cybersecurity services company Cloudrise and served as COO through its 2024 acquisition. Earlier he led Deloitte Fusion Managed Services operations. His issuer-linked LinkedIn identity is joseph-infantino-47620266; unrelated broker and realtor namesakes are excluded.

Osama Zahid is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Advocate Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Galileo Ventures is an Australian pre-seed and seed venture capital firm that backs emerging founders developing AI software, robotics, hardware and deep technology for global markets. It often provides the first institutional cheque and supports companies through product development, commercialisation, recruitment and further fundraising. Its partners operate from Sydney, Melbourne and San Francisco, connecting Australian technical founders with US customers and investors. Founded in 2020 by James Alexander and Hugh Stephens, it has backed companies including Relevance AI, Andromeda Robotics, Kite Magnetics and brain-computer interface developer Fluent BCI. Its second fund adds follow-on reserves while retaining the focus on early technical teams.

As General Partner, Aaron leads the Investment Team at GD1. He has over 10 years experience in Venture Capital roles in both NZ and the UK. Before joining GD1, Aaron was an Investment Manager at NZTE where he helped NZ technology companies connect with local and international VCs. Prior to this, Aaron managed Spark NZ's Corporate VC program and held investing roles at Aspinall Capital (a $100m industrial technology fund) and WHEB Partners (a cleantech venture capital firm with €250m AUM) in the United Kingdom. Aaron holds a PhD in Chemistry and a BSc Hons (1st Class) from Victoria University of Wellington and the MacDiarmid Institute of Advanced Materials and Nanotechnology. He is passionate about supporting NZ founders in taking their technologies global to solve the world's biggest challenges.

Catherine has a passion for building systems; a talent for juggling multiple responsibilities and thrives on the challenge of solving difficult problems by imagining what they might look like fixed. As an owner/operator for 20 years, her business management experience was gained at the coal face where she did 'whatever it took' to ensure the success of the company, including liaising with clients in over 60 different countries; project management on high budget productions; negotiating international sponsorships, dealing with a variety of stakeholders and at all times handling the day to day of running a business. Catherine's 'specialist generalist' background is an invaluable asset to GD1 where she applies what she knows about systems, processes, policies and procedures to set the company and its portfolio companies up for success. "Operations management aims at understanding the bigger picture so that you can review, decipher and problem-solve around each roadblock with an eye on how everything you do fits into and will help achieve the company's overarching objectives while remaining compliant and on track."

Doug has nearly 15 years of experience working in sales, marketing, and customer success. He provides in-the-trenches, functional Go To Market support to GD1's portfolio, empowering our companies to make smart decisions and execute successfully so they can achieve global growth. Doug specialises in helping our founders and their teams succeed post investment which is a core part of what we do here at GD1. "Venture capital attracts brave, daring and determined people - being around startups and helping them is what makes me excited about being in VC..."

Hugh Stephens co-founded Galileo Ventures after founding Schedugram in 2013 and growing the bootstrapped company, later renamed Sked Social, into a platform used by more than 10,000 brands. He previously worked in management consulting and Melbourne startups, advises portfolio companies and is a Board Observer at Zendir.

James Alexander co-founded Galileo Ventures. He founded INCUBATE at the University of Sydney and expanded the startup program across five universities, helping launch more than 200 startups. He previously worked as an engineer at startups including Atlassian and is a Board Observer at Relevance AI.

Jin is a software engineer, technology leader and founder who has spent his career building technology products and teams. He was an early employee at Vend, which was acquired by Lightspeed, and has since worked across a range of startups and technology businesses, including Serato, ANZ and Basis. He is the co-founder and CTO of Journey Health, a digital health startup, and organises the Prompt Poets Society, an Auckland community focused on AI engineering and emerging technology.

John has 20+ years investment experience, including 14 years in the UK. He spent 3 years as a front office equity analyst for London based hedge fund GLG Partners (previously one of the largest hedge funds globally before being acquired by Man Group). He then went on to work for 8 years at Tesco Pension Investment, a £14B UK pension scheme, as Head of Alternatives - creating, allocating and managing £1.5B in alternative investments globally. John has also been an active angel investor for a number of years. Upon returning to New Zealand in 2015, he co-founded an e-commerce start-up before joining GD1 in 2017. He holds a BSc (Mathematics), 3x Diplomas in Finance, Financial Planning and Statistics, and is a CFA Charterholder. John most recently led investments for GD1 Core Fund 1 into: Auror, Formus Labs, Runn.io, VXT, Simfuni, NextWork, Buddy, Flowingly, Orbica, and Vessev.

Jono sits within the Investment Team, supporting the Partners across the full investment process, from sourcing through diligence, investment and post-investment. He currently holds several Board Observer roles at select GD1 portfolio companies. Prior to joining GD1, he held corporate finance and advisory roles at Grant Thornton and Westpac, and led infantry platoons as a Platoon Sergeant in the Singapore Armed Forces. JT holds a BCom from the University of Auckland and is a Chartered Accountant. Jonathan is excited to learn about new technologies and work with founders to succeed and scale their startups globally.

Julia French joined Galileo in late 2024 as its first head of platform and became a partner at the end of 2025. Her operating and investing experience spans Silicon Valley and Australia, including work with founders of Atlassian, Dropbox and WhatsApp and firms including AirTree and Sequoia. She previously served as Course Director and Senior Lecturer in the Transdisciplinary School at UTS. Her personal startup investments are distinct from Galileo manager holdings.

Luke Norris co-founded Kamiwaza and is its Chief Executive Officer. SEC filings identify him as Luke Matthew Norris, an executive officer and director of Kamiwaza Corp. The company develops distributed enterprise AI orchestration for regulated and government customers.

Matt Wallace co-founded Kamiwaza and is its Chief Technology Officer. SEC filings name him Matthew Wallace, an executive officer and director of the same Kamiwaza Corp. His work centers on enterprise AI, distributed data and inference infrastructure.

With the ability to discover the genius in others and a passion for journeying with early stage founders, Nawaz is a respected authority in the crypto/web3 space. Since 2019, he has been an avid angel investor - investing in over 15 early stage crypto companies, including US-based. As an entrepreneur, he has been through all of the phases of successfully starting a company - ideating, coming up with a product proposition, executing on that vision, and selling. His current focus at GD1 is on raising and investing for the Web3 Fund, meeting founders who are leveraging crypto/web3 tech to build new and exciting businesses.

Samuel Young is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Humana. This is an advisory or cohort network affiliation, rather than a firm employee position.

Tracy is an all-rounded professional with extensive experience in project management, people & culture, and business operations. She has successfully led and supported a variety of projects across different contexts and worked across corporate, non-profit and ed-tech. Tracy is deeply passionate about diversity, equity, inclusion and sustainability, and she currently serves on the board of Tāhono Inclusive Collective Aotearoa and the APEC Voices Trust New Zealand. Before joining GD1, Tracy completed her Master of Business in Diversity Management. Her expertise lies at the intersection of people, projects, and processes, where she excels in collaborating with diverse teams to tackle complex challenges and develop innovative solutions.

Vignesh Kumar is Co-Managing Partner at GD1. He previously co-founded digital oncology platform Journey Health, led engineering execution at Apple across the US and Asia, and designed neonatal resuscitation technology at Fisher & Paykel Healthcare. He is a Kauffman Fellow and Fulbright Scholar with an MBA from Wharton and biomedical engineering qualifications from the University of Auckland.

Kelly Wang is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Cornell University, Cornell Tech. This is an advisory or cohort network affiliation, rather than a firm employee position.

Kamiwaza is a Silverthorne, Colorado enterprise AI software company legally identified in SEC filings as Kamiwaza Corp., a Delaware corporation formed in 2024. Co-founders Luke Norris and Matt (Matthew) Wallace lead the company as CEO and CTO. Its distributed AI orchestration platform connects models, enterprise data and applications across cloud, on-premises and edge infrastructure while keeping data within the customer’s security perimeter. The platform combines a distributed data engine, inference mesh, contextual ontologies and governance tools for regulated businesses and government, including healthcare, finance and secure document workflows. Kamiwaza 1.0 became generally available in 2026; supported deployments and partner integrations are distinguished from investor relationships. SEC filings verify two completed offerings: $2.5 million pre-seed and $8,499,913 seed, rounded to $8.5 million in the company’s January2025 announcement. The announced $11 million is their combined total, not an additional round. S3 Ventures and Pioneer Square Labs were named seed co-leads. Three August2026 operating hires expand commercial, federal and finance leadership. Former Field CTO James Urquhart’s own recent departure statement supersedes older company appointment pages; an exact departure day is not disclosed. No separate paid SeriesA or corporate investment portfolio has been verified.

Gina-Marie Verrone is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Atlantic Health System. This is an advisory or cohort network affiliation, rather than a firm employee position.

Lucie Tyrrell is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Humana. This is an advisory or cohort network affiliation, rather than a firm employee position.

Medical simulation entrepreneur who founded Mentice and worked on its US operations and global commercial partnerships.

Koios Care is a Belgian digital health company developing Parkiwatch to help people with Parkinson’s understand everyday changes in their condition. Its software collects passive data from ordinary smartphones and smartwatches and converts movement, rest and other sensor signals into digital measures of gait, tremor, sleep, activity and quality of life. Patients control whether to share their data with care teams. The company also provides dashboards and real-world measures for clinicians and neuroscience research. Koios describes its current offering as a wellness solution rather than a medical device; it does not diagnose or treat disease.

ORamaVR is a Swiss medical simulation company with research operations in Crete. It develops software for immersive training on medical devices, surgical robots and clinical procedures. Its Creator authoring tools let customers build VR training simulations, while a cloud Virtual Training Center distributes courses and records practice and competency assessments. The company supplies a simulation library and custom simulation services. Its JARIA AI proctor uses procedural and device instructions to guide trainees and assess sessions. Customers include medical device manufacturers, hospitals and simulation centres.

Business development professional with experience in exports and administration and degrees from King’s College London and Aristotle University.

Adviser on regulatory strategy; LL.M. and MBA.

Charlotte Thomas is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Signify Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Professor of electrical engineering and computer science at Stanford University.

Orthopaedic surgeon and professor affiliated with Aristotle University and Imperial College London.

Computer scientist with an MSc focused on XR and experience leading medical simulation products.

Neurology professor at CHU Liège.

Lawyer specialising in corporate and commercial law and technology transfer; College of Europe graduate.

Computer scientist working on computer graphics and XR algorithms; professor at the University of Crete, formerly at the University of Geneva.

Clinical oncologist and business adviser.

Koios identifies Kourtis as a Gates Ventures ADDF leader, founder and investor. Lampros Kourtis leads the Gates Ventures Diagnostics Accelerator SpeechDx program, according to the March 2026 ADDF Alzheimer’s Insights Summit. His work concerns longitudinal speech research as a potential source of biomarkers across languages. His published biography describes co-founding Chronicles Health, earlier biomaterials ventures, an engineering leadership role at Eli Lilly and a Stanford mechanical-engineering doctorate. These are research activities, not a claim of diagnostic approval.

Software engineer and researcher working on VR, machine learning and skills assessment.

University of Crete and ICS-FORTH professor working on computer vision, robotics and augmented reality.

Koios identifies him as a professor at Karolinska.

Chelsea Sumner is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as NVIDIA. This is an advisory or cohort network affiliation, rather than a firm employee position. A longer individual biography is not published on the manager page.

Erica Stutz is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Yale University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Henry La Soya is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Novo Holdings. This is an advisory or cohort network affiliation, rather than a firm employee position. Henry joined Novo Holdings Equity US in October 2021 as an Associate in Principal investments. He participates in deal sourcing and execution and manages investments across the healthcare sector as a part of our Boston office. Prior to Novo Holdings, Henry served as a consultant at Roland Berger for two years, primarily focusing on the industrials space. He also began his career with consulting internships in the healthcare space at Clarion and Thrive Consulting. Henry holds a BS in Bioengineering with a Finance minor from Massachusetts Institute of Technology (MIT).

Kate Schnitzer is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as The Wharton School at the University of Pennsylvania. This is an advisory or cohort network affiliation, rather than a firm employee position.

Aaron Sacks is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as UnitedHealth Group. This is an advisory or cohort network affiliation, rather than a firm employee position.

Amalia Roth is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Kellogg School of Management at Northwestern University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jeff Rosenzweig is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Inova Health Systems. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jack Rogoff is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Fresenius. This is an advisory or cohort network affiliation, rather than a firm employee position.

Glenna Roberts is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Harvard Business School, Harvard Kennedy School. This is an advisory or cohort network affiliation, rather than a firm employee position.

Mckenzie Rhone is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Chicago Booth. This is an advisory or cohort network affiliation, rather than a firm employee position.

Nathaniel Perez is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Duke University, Fuqua School of Business. This is an advisory or cohort network affiliation, rather than a firm employee position.

Sara Parsons is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Point32Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Shreeya Panigrahi is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Stanford University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Murtaza Mubin is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Stanford University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Marcy Medlak is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Elevance Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Michelle Matvey is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as MIT Sloan. This is an advisory or cohort network affiliation, rather than a firm employee position.

John Machalek is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Elevance Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Brett Libowitz is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as University of Pennsylvania, The Wharton School. This is an advisory or cohort network affiliation, rather than a firm employee position.

Pranav Kuber is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Piction Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Zoey Li is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as MIT Sloan. This is an advisory or cohort network affiliation, rather than a firm employee position.

Christine Kohn is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Harvard T.H. Chan School of Public Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jesse Kesner is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Harvard University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Lea Jabbour is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as University of Chicago Booth School of Business. This is an advisory or cohort network affiliation, rather than a firm employee position.

Priya Khatri is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Memorial Hermann. This is an advisory or cohort network affiliation, rather than a firm employee position.

Ellie Hwang is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as MedStar. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jessie Huang is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Tuck School of Business. This is an advisory or cohort network affiliation, rather than a firm employee position.

John Hwang is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as University of Pennsylvania, The Wharton School. This is an advisory or cohort network affiliation, rather than a firm employee position.

Lawrence Huang is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Warren Alpert Medical School of Brown University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Charlotte Grimm is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Kellogg School of Management at Northwestern University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Sarah Holmes is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Cleveland Clinic. This is an advisory or cohort network affiliation, rather than a firm employee position.

Dominik Gorecki is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as University of California, Berkeley. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jim Fitzgerald is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Knownwell. This is an advisory or cohort network affiliation, rather than a firm employee position.

Ethan Emde is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as AdventHealth. This is an advisory or cohort network affiliation, rather than a firm employee position.

Bradley Dollens is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Parkview Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Mary Dinnean is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Boston University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Kendall Dexter is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Blue Cross NC. This is an advisory or cohort network affiliation, rather than a firm employee position.

Micah Dean is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Cincinnati Children's. This is an advisory or cohort network affiliation, rather than a firm employee position.

AIATELLA develops artificial intelligence software that automates measurements in cardiovascular imaging. Its Automated Image Measurement technology analyses MRI, CT and ultrasound scans to quantify blood-vessel abnormalities and changes over time, helping clinicians assess patients without manually measuring each image. The Finnish company also develops portable ultrasound screening for carotid artery disease, aiming to identify cardiovascular risks before symptoms appear.

Psylink is a Lithuanian biotechnology company developing small-molecule medicines for mental health conditions, including treatment-resistant depression and PTSD. It engineers yeast to biosynthesise plant- and fungi-derived compounds, including psilocybin and related molecules, and screens new compounds for further drug development. Its platform aims to provide a scalable supply of research materials while discovering potential next-generation therapies through neuroscience and natural-product research.

Rahina Damji is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Columbia Business School. This is an advisory or cohort network affiliation, rather than a firm employee position.

Andrew Croll is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as CVS Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Prasidh Chhabria is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Percepta. This is an advisory or cohort network affiliation, rather than a firm employee position.

Henry Chen (Apple) is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Apple. This is an advisory or cohort network affiliation, rather than a firm employee position. This Apple/Google Health clinical-operations professional is distinct from the Delos Capital investor of the same name.

Madeline Chaillet is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as University of Virginia Darden School of Business. This is an advisory or cohort network affiliation, rather than a firm employee position.

Candace Carlson is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Hartford Healthcare. This is an advisory or cohort network affiliation, rather than a firm employee position.

Brandy Bittenbender is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as LabCorp. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jack Cai is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Boston Children's Hospital. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jesse Bissen is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Allina Health. This is an advisory or cohort network affiliation, rather than a firm employee position.

Justin Bier is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Cox. This is an advisory or cohort network affiliation, rather than a firm employee position.

Julien Bendelac is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Stanford University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Vanessa Baillie is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Medtronic. This is an advisory or cohort network affiliation, rather than a firm employee position.

Maya Ambady is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as University of Michigan. This is an advisory or cohort network affiliation, rather than a firm employee position.

Rushil Arora is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Pomelo Care + Stanford University. This is an advisory or cohort network affiliation, rather than a firm employee position.

Brett Adkins is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Boston Children's Hospital. This is an advisory or cohort network affiliation, rather than a firm employee position.

Matt Stein is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Chief Information Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

William Sheahan is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Senior Vice President and Chief Innovation Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Brandon Seibold is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Chief Growth Officer and Treasurer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jared Saul is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Former Chief Medical Officer, Commercial Health & Life Sciences (External Advisor). This is an advisory or cohort network affiliation, rather than a firm employee position.

Todd Ponsky is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Chief Innovation Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Ganesh Persad is listed in Flare Capital Partners’ current public directory as Flare Scholar, 2026 cohort. The directory describes the external professional affiliation as Vice President & Chief Information Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Tilak Mandadi is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Executive Vice President, Ventures and Chief Experience and Technology. This is an advisory or cohort network affiliation, rather than a firm employee position.

Katie Catlender is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Executive Vice President and Chief Operating Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Sean Bruich is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Chief Technology Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Svetlana Bender is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Vice President, Artificial Intelligence & Behavioral Science. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jeff Weiss is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Executive Vice President, Enterprise Strategy & Strategic Partnerships. This is an advisory or cohort network affiliation, rather than a firm employee position.

Marcus Wallace is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Chief Medical Officer and Vice President, Clinical Operations and Innovation. This is an advisory or cohort network affiliation, rather than a firm employee position.

Anna Zink is Head of Data Science at Knit Health Technologies. She is named on the company’s current leadership roster and is a co-author of the foundational Deep Causal Behavioral Policy Learning: Applications to Healthcare research with Jonas Knecht, Jonathan Kolstad and Maya Petersen. Her work contributes to the causal and behavioral modeling underlying Knit’s healthcare AI.

Anshul Amar is Co-Chief Technology Officer of Knit Health Technologies, serving alongside co-founder Jonas Knecht. He is named on the company’s current public leadership roster. His public professional profile identifies healthcare technology experience and patents concerning automated image classification, provider negotiated rates, and practice management and billing automation.

Chase Tacker is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Senior Vice President, Corporate Development. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jonas Knecht is co-founder and Co-Chief Technology Officer of Knit Health Technologies. A UC Berkeley doctoral researcher in econometrics and computational precision health, he developed the computational architecture behind Knit’s Large Clinical Behavior Model. His work combines behavioral data and computational methods to model clinical decisions.

Jonathan Kolstad is co-founder and CEO of Knit Health Technologies, the UC Berkeley spinout developing Large Clinical Behavior Models for healthcare. He is a UC Berkeley Haas professor and Henry J. Kaiser Chair in Economic Analysis and Policy. His research on healthcare economics and clinical decision-making helped establish Knit’s behavioral approach to healthcare AI.

Maya Petersen is co-founder and Chief Scientist of Knit Health Technologies. A physician and UC Berkeley professor of epidemiology, biostatistics and computational precision health, she is co-director of the joint UCSF–UC Berkeley Computational Precision Health programme. Her causal inference expertise informs Knit’s efforts to distinguish observed clinician behavior from optimal patient-specific decisions.

Midori Uehara is Chief Growth Officer of Knit Health Technologies. The current company roster identifies her leadership role, and her own public launch announcement confirms joining the company’s clinical intelligence team. Knit develops healthcare AI trained on real clinical decisions and patient pathways.

Rick Talento is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Chief Financial Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Sophie Pinkard is Chief Product Officer of Knit Health Technologies. The company’s public roster and named testimonial identify her product leadership role in applying clinical intelligence to healthcare workflows and improving care delivery. Her public professional biography describes experience leading healthcare product teams.

Ted Robertson is co-founder and Chief Operating Officer of Knit Health Technologies and executive director of UC Berkeley’s Center for Healthcare Marketplace Innovation. His background in behavioral economics, product design and organization building supports translating Knit’s clinical intelligence research into products health systems can deploy.

Zoey Ma is an AI Engineer at Knit Health Technologies. The company identifies her in a named public team testimonial, alongside an authentic portrait. She describes joining Knit to work on cutting-edge AI research that improves people’s lives; the company develops Large Clinical Behavior Models for healthcare systems.

Barry Stein is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Vice President, Chief Clinical Innovation Officer and Chief Medical Informatics Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Sue Siegel is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Former Chief Innovation Officer and Former Chief Executive Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Susan K. Nelson is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Executive Vice President and Chief Financial Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Knit Health Technologies, Inc., branded Knit Health, is a UC Berkeley healthcare AI spinout developing a Large Clinical Behavior Model (LCBM) that learns from real clinical decisions and patient journeys. Its infrastructure layer combines behavioral cloning, causal inference and reinforcement learning to support specialist routing, patient flow, care-team allocation, clinical variation analysis and proactive care recommendations. A Truveta collaboration announced in May 2026 supports training using electronic health records spanning more than 130 million patients across 30 US health systems. The company describes privacy safeguards and HIPAA-aligned deployment, while its founders describe ongoing pilot development rather than demonstrated clinical effectiveness across all uses. Co-founders are CEO Jonathan Kolstad, Chief Scientist Maya Petersen, Co-CTO Jonas Knecht and COO Ted Robertson; the published current roster also names Sophie Pinkard, Anshul Amar, Anna Zink, Midori Uehara and engineer Zoey Ma. The company launched with USD 11.6 million seed funding on 12 May 2026 co-led by Uncork Capital and Frist Cressey Ventures. An earlier pre-seed was led by Moxxie Ventures with Coalition Operators; its separate amount and exact date are undisclosed. This legal entity and knit.health brand are distinct from historical Knit Health Inc. at knithealth.com, a 2010s computer-vision sleep-device business founded by David Janssens, Paul Silberschatz and Evan Shapiro. Historical sleep-company financial records and personal checks remain attributed separately. The privacy policy identifies the exact legal name and an earlier knithealth.ai website reference.

Matthew Morgan is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Senior Vice President and Chief Financial Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Juan Lopez is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Executive Vice President, Chief Financial Officer, and Treasurer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jessica Lee-Hansen was named chief financial officer for Parkview Health in July 2025. She is responsible for management oversight and direction over financial strategy and planning, accounting and reporting, capital planning, revenue cycle services, and treasury. As a member of Parkview’s executive leadership team, she serves as a strategic financial advisor to executives and the board of directors. Prior to joining Parkview, Lee-Hansen worked as an investment banker for two global financial services organizations, starting as a summer analyst and working her way up to a managing director position. She served as a strategic financial advisor to an impressive and diverse portfolio of clients, including health systems, physician groups, value-based organizations, and payors. Lee-Hansen has also been recognized as an emerging leader, participating in a variety of leadership programs and councils. Her experience, which is vital to supporting continued growth, helps drive Parkview’s mission to improve health and inspire well-being. Lee-Hansen holds a bachelor of arts in economics and political science from Columbia University. Her existing FlareCapitalPartners externalIndustryAdvisoryBoard affiliation is separately preserved.

Isaac Kohane is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Professor and Chair, Department of Biomedical Informatics. This is an advisory or cohort network affiliation, rather than a firm employee position. A physician and biomedical informatics researcher, known as Zak, whose work includes medical artificial intelligence and neurodevelopmental genomics.

Kelly Ko is listed in Flare Capital Partners’ current public directory as AI Advisory Council member. The directory describes the external professional affiliation as Vice President of Technology Ventures and Innovation. This is an advisory or cohort network affiliation, rather than a firm employee position.

Timothy Howe is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Assistant Vice President, Health Care Strategy and Investments. This is an advisory or cohort network affiliation, rather than a firm employee position.

Gregory Grunberg is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Head of Life Sciences & Healthcare, North America. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jeffrey E. Graff is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Senior Vice President/Treasury and Chief Corporate Development Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jonathan Gruber is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Ford Professor, Economics and Chairman, Economics Department. This is an advisory or cohort network affiliation, rather than a firm employee position.

Beau Garverick is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Senior Vice President, Corporate Development and Strategy. This is an advisory or cohort network affiliation, rather than a firm employee position.

Steven C. Glass is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Former President and Chief Executive Officer. This is an advisory or cohort network affiliation, rather than a firm employee position.

Aaron Foster is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Vice President, Business Analytics and Insights. This is an advisory or cohort network affiliation, rather than a firm employee position.

Jeffrey Fedder is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Head of Corporate Development and Strategic Investments. This is an advisory or cohort network affiliation, rather than a firm employee position.

Sandra L. Fenwick is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Chief Executive Officer, Emeritus. This is an advisory or cohort network affiliation, rather than a firm employee position.

Yao Fang is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Executive President. This is an advisory or cohort network affiliation, rather than a firm employee position.

Justin Strausbaugh is named as a manager of TensilityIII LLC in its July2026 regulatory filing, alongside Tensility co-founders Wayne Boulais and Armando Pauker. His former employer Alumni Ventures identifies him as the former managing partner of Lakeshore Ventures and a University of Chicago Booth graduate. The current Tensility website directory omits Justin; the legal vehicle role is dated to the2026 filing rather than inferred from an undated third-party partner title.

Flow Computing is a Finnish semiconductor company developing licensable processor architecture and compiler technology to accelerate general-purpose parallel computing. Its Flow PPU, or Parallel Processing Unit, is an on-die coprocessor designed to work alongside conventional CPU cores, improving how parallel workloads execute without tying the technology to a particular instruction set or chip foundry. CPU vendors can configure the architecture for different processor designs, while Flow’s compiler tools help existing software use the parallel hardware. The company initially targets AI cloud CPUs, with planned applications in robotics, autonomous systems and consumer devices. Flow spun out of VTT Technical Research Centre of Finland in 2024.

Medical-device entrepreneur, investor and adviser to growth companies, with experience developing medical software businesses.

Investor and company director across ICT, technology, medical technology and circular economy; CEO of Foregreen Investments and chairman of Profium.

Investor and company director with a background as a partner at Roschier and experience in mergers and acquisitions, healthcare, retail and ICT.

Business leader with experience in international sales and marketing at Instrumentarium, SpaceLabs Healthcare and GE Healthcare, including operating-room and intensive-care monitoring businesses.

Sreekanth Chaguturu is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Executive Vice President and​ Chief Medical Officer​. This is an advisory or cohort network affiliation, rather than a firm employee position.

Brian Caveney is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Chief Medical and Scientific Officer. This is an advisory or cohort network affiliation, rather than a firm employee position. Labcorp public biography: Brian Caveney, M.D., J.D., M.P.H. Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer Brian Caveney, M.D. has served as Executive Vice President and President, Biopharma Laboratory Services and Chief Medical and Scientific Officer at Labcorp since September 2026 and previously served as Labcorp’s Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer at Labcorp from 2023 to 2026. From 2019 to 2023, he served as EVP and President, Diagnostics and Chief Medical Officer. From 2017 to 2019, he served as Senior Vice President and Chief Medical Officer. In his current role, Brian leads our global biopharma laboratory services business, in addition to medical and scientific affairs, research and development, and quality for Labcorp. Since joining Labcorp in 2017, Brian has been instrumental in accelerating growth in the company’s business units and advancing its medical and scientific strategy. Under his leadership, the company has expanded diagnostic testing services, introduced new assays across key therapeutic areas, and expanded its hospital strategy. During the COVID-19 pandemic, Brian led efforts to expand the accessibility of PCR testing, used his expertise to help bring understanding about testing and treatment options to the public, and drove advancements to the way the company works with the broader healthcare industry. Before joining Labcorp in 2017, Brian was the Chief Medical Officer at Blue Cross and Blue Shield of North Carolina. In addition to various roles in the healthcare division of the core health plan, Brian also served as Chief Clinical Officer of Mosaic Health Solutions, a wholly-owned subsidiary of Blue Cross NC, for strategic investments in diversified health solutions businesses. Previously, he was a practicing physician and assistant professor at Duke University Medical Center. Brian serves on the Board of Directors of the Personalized Medicine Coalition, the Healthcare Leadership Council, and North Carolina Healthcare Quality Alliance. He is a Board Observer for CND Life Sciences, Inc. He holds a Doctor of Medicine from the West Virginia University School of Medicine, a Juris Doctorate from the West Virginia University College of Law, and a Master of Public Health from the University of North Carolina at Chapel Hill. He completed his residency at Duke University Medical Center and is board certified in preventive medicine, with a specialty in occupational and environmental medicine.

Jen Barrera is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as Senior Vice President, Strategic Implementation. This is an advisory or cohort network affiliation, rather than a firm employee position.

Thomas Brouillard is listed in Flare Capital Partners’ current public directory as Industry Advisory Board member. The directory describes the external professional affiliation as CFO Global Care Delivery. This is an advisory or cohort network affiliation, rather than a firm employee position.

Cerenion is a Finnish medical-device company developing AI-assisted monitoring of brain activity for acute healthcare. Its C-Trend EEG Station combines a disposable electrode array, EEG amplifier and quantitative analysis software to record brain electrical activity and display continuous trends for clinicians. The software measures slow-wave activity, burst suppression, amplitude-integrated EEG and alpha-delta ratios, helping intensive-care teams review changes in brain function alongside the original EEG recordings. The system is designed to make continuous EEG monitoring accessible to doctors and nurses who are not EEG specialists; the software does not itself provide diagnostic conclusions.

Chris Hocevar is listed in Flare Capital Partners’ current public directory as Executive Partner. The manager’s own biography documents this healthcare investment, operating or platform position.

Phyllis Gotlib is listed in Flare Capital Partners’ current public directory as Executive Partner. The manager’s own biography documents this healthcare investment, operating or platform position.

Graham Gardner is listed in Flare Capital Partners’ current public directory as Executive Partner. The manager’s own biography documents this healthcare investment, operating or platform position.

Flare senior associate supporting healthcare technology investments. Previously advised pharmaceutical and healthcare companies at ZS Associates on innovation, digital strategy, analytics organization and commercial diligence; her own biography also describes venture experience at53Stations.

Flare controller supporting finance and operations since2025. Previously managed private-equity and venture fund reporting at Summit Partners and spent eight years in KPMG audit, reaching senior manager. A Massachusetts CPA and UMass Amherst accounting graduate.

Flare executive assistant who joined inJuly2024 and supports investment and platform leadership. Previously worked in office and operations administration at B-FLEXION. Earned a sociology degree at Bridgewater State University.

Flare principal with experience incubating healthcare startups at Redesign Health and leading operations and strategy work at Flatiron Health. Earlier advised pharmaceutical commercialization and market access at Putnam Associates. Holds a McGill economics degree and Wharton MBA.

Executive assistant at Flare, joining inDecember2024 to support partners Michael Greeley, Adam Bruce, Ian Chiang and Margaret Malone. Previously supported Cohere Health’s executive leadership as operations coordinator. A University of Maryland public-health graduate.

Flare partner focused on technology-supported care, payer/provider infrastructure, healthcare workforce and life-sciences platforms. Earlier helped healthcare founders build executive teams at Oxeon, invested at7wire and B Capital, and advised clinical operations at Huron.

Healthcare venture partner at Flare, also known as Vic. His own biography identifies leadership of investments in Elektra Health, Greater Good Health, Lynx and Ounce of Care. Previously worked in Curaspan corporate development and naviHealth product strategy, with earlier healthcare consulting at PwC and McKinsey.

Flare senior associate investing in healthcare software, data and artificial intelligence. Previously led AI strategy work at Harvard Medical School and held data engineering and business-strategy roles at PathAI. Earned an MIT Sloan MBA and also appears in the firm’s2026 Scholar cohort; the later senior-associate biography controls her staff position.

Andrew Cafourek’s own professional website identifies him as VP and head of technology at Anthos Capital, managing technical infrastructure and evaluating emerging technology for internal workflows. His biography describes prior product and digital-technology work at Lat Long and Alumni Spaces. He received a 2022 master’s in global management with a space-leadership, business and policy specialization at Thunderbird/Arizona State and studied political science at Missouri. The VP title is reproduced from the primary biography; a later promotion is not independently asserted.

Brian Ames formerly served as managing director and head of growth at Anthos Capital. Savers Value Village’s April 2026 proxy explicitly describes the Anthos role as former, overriding stale investor directories. His previous operating experience included president and general manager of Activision Blizzard Media. He joined Anthos in 2021 according to issuer biographies, but an exact departure day is unpublished and not inferred from his August 2025 Savers board appointment. Distinct from the actor and unrelated people with this name.

Bryan Hale is an investor at Anthos Capital and is publicly named as an organizing-team member of the April 2026 Seattle AI Startup Summit. His own professional announcement describes joining Anthos following four years at the Allen Institute for AI Incubator and continuing a separate incubator-fund investor affiliation. Harvard education is published on his own profile. He is distinct from Haley Bryant and other similar-name people.

Bryan Francis Kelly is a co-founder and principal owner of Anthos Capital. The firm’s March 2026 ADV names him as a limited partner and control person since July 2007, and July 2026 issuer SEC filings identify him and Paul Farr as managers of Anthos Management and related fund general partners. His own professional profile identifies Stanford Law School study. Distinct from the composer and unrelated investors sharing this name.

Flare vice president leading investor relations and fundraising communications. Previously worked in investor relations at RA Capital and Bain Capital, corporate development at Relay Therapeutics, and investment consulting at Cambridge Associates.

Emily White is president of Anthos Capital, serving since 2018 according to current issuer biographies. Her previous technology leadership included COO of Snap and roles at Instagram, Facebook and Google. Lululemon’s current director biography describes her oversight of investments including Gretel.ai and Laurel.ai and her work in digital advertising and emerging technologies. She holds a Vanderbilt art-history degree. This executive is distinct from the existing Greenbrook clinical-operations professional also named Emily White.

Frances Au-yang’s own public professional profile identifies a Santa Monica-based Anthos Capital affiliation and study at the University of California, Los Angeles from 2005 to 2009. A precise current functional title and independently sourced full biography are not published in the accessible primary profile; a third-party vice-president title is not assumed.

Gavyn Davies is a limited partner and control person of Anthos Management in its March 2026 regulatory filing, recorded since July 2007. This identifies ownership of the management partnership, not a proven day-to-day executive job or a particular portfolio-company check. His current Fulcrum Asset Management biography identifies him as founder and executive chairman, formerly BBC chairman and Goldman Sachs chief economist, with Cambridge economics study and Oxford research.

Jeffrey Paul Farr, publicly known as Paul Farr, co-founded and co-leads Anthos Capital. Its March 2026 ADV identifies him as a principal owner and limited partner since July 2007. Cambrian Bio’s current director biography describes his previous investment work at Summit Partners and Goldman Sachs and degrees from McGill and Stanford. He also serves on Cambrian’s board; no personal financing participation is inferred.

Randall Robert Chandler, publicly known as Randy Chandler, is chief financial officer of Anthos Management, the legal adviser operating as Anthos Capital. The March 30, 2026 ADV names him as CFO and records the role since February 2020; he signed that filing as CFO. His own professional profile lists USC Marshall education, CFA qualification and inactive CPA status. Exact appointment day is not inferred from a month/year.

Sue Choe is publicly affiliated with Anthos Capital in her current professional profile and own recruiting posts. Her 2024 conference biography identifies her as head of people and portfolio talent, supporting both the firm and portfolio companies, following people-leadership roles at Petal and Venmo. She studied at Harvard Business School. The published 2024 title is qualified; no later COO promotion is asserted without primary confirmation. Her named original conference portrait is not retrievable; no replacement portrait is invented.

Yvonne I. Pytlik is named as Anthos Capital’s chief compliance officer in its March 2026 ADV, with the role recorded since July 2022. Columbia University’s current faculty biography identifies her as an outsourced chief compliance officer at ACA Group and an enterprise risk management lecturer. Her earlier compliance leadership includes HSBC and Deutsche Bank. This is a source-qualified outsourced compliance affiliation, not an assumed internal employment arrangement.

Physician and healthcare investor serving as Flare partner. Practiced internal medicine at Massachusetts General Hospital and taught at Harvard Medical School from2010–2019. Earlier Harvard Pilgrim medical-director work covered population-health analytics and value-based purchasing, alongside health-technology entrepreneurship and policy advising.

Healthcare venture investor known as Jon or JG, serving as Flare vice president. Focuses on care delivery, AI and machine learning, with earlier experience at OCA Ventures, Wittington Ventures, Mayo Clinic and healthcare consultancy Chartis. Was a Flare Scholar in2022.

Flare vice president responsible for marketing and platform support, including communications, content, events and healthcare ecosystem partnerships. Previously researched digital health at CB Insights and was an early Health Tech Nerds team member.

Flare healthcare investment partner with experience in policy, operations and venture investing. His current primary biography describes involvement with clinical AI at SmarterDx, Daffodil, Layer and Photon, and earlier healthcare AI investing at NewYork-Presbyterian Ventures. Company board appointments and personal cash attribution are not inferred from this summary.

Healthcare venture finance and operations executive, serving as Flare partner, CFO and COO. Previously spent more than14years at Advanced Technology Ventures, including CFO, and also served as Lightstone Ventures CFO. Earlier worked in investment banking at DLJ and Credit Suisse First Boston.

Roel Kellenaers served as MRIguidance CEO from January 2025 until February 2026, when Guido Zijl succeeded him. The issuer announced his CEO appointment on 23 January 2025 after 14 months as Chief Commercial Officer. It describes marketing, sales, strategy and business-development experience in life sciences. An exact CCO start day is not inferred from the month-level duration.

Roel Raatgever co-founded MRIguidance with Peter Seevinck and Marijn van Stralen in 2016 and served as CEO. The issuer announced his death on 1 December 2021 after a traffic accident during a US business trip. It named the two other founders as temporarily covering his leadership duties. The exact day of death is not disclosed, so the announcement date is not entered as an invented tenure end.

Addie Harris is a member of MRIguidance’s current advisory board, as named by the company. Her genuine portrait is published beside the named affiliation. The appointment date and any personal equity investment are undisclosed.

Kornelis Poelstra is a member of MRIguidance’s current medical advisory board. The issuer also describes his BoneMRI spine-surgery work at the Robotic Spine Institute of Las Vegas. The advisory role and clinical use do not establish a personal financing check.

René Castelein is a member of MRIguidance’s current medical advisory board, as named by the company. His research co-authorship and genuine issuer portrait support the scientific affiliation but do not establish an executive position or personal investment.

Hilde Geraedts is MRIguidance’s Senior Clinical Affairs Manager. The current company directory describes experience in clinical and scientific research across medical fields, used to develop the clinical evidence supporting BoneMRI.

Kees van Wijk is MRIguidance’s Senior Software Architect. According to the current company directory, he has more than 15 years of experience in the medical domain and focuses on practical software solutions. His exact appointment date is not published.

Manuela Escobar is MRIguidance’s Marketing & Communications Manager. The current company directory identifies her work communicating BoneMRI to clinicians and healthcare partners. Its linked personal profile uses the fuller name Manuela Escobar Sanz de Santa Maria.

Rick Bergmans is MRIguidance’s Deep Learning Lead. His current issuer biography describes developing clinically relevant deep-learning solutions and structured, high-quality medical-imaging data pipelines.

Stijn van Wijngaarden is MRIguidance’s Deep Learning Engineer. The current company directory describes combining MR physics and deep learning to develop medical-imaging technology for healthcare.

Tijl van der Velden is MRIguidance’s Clinical MRI Specialist. His current company biography describes implementing MRI sequences, managing artifacts and improving patient comfort while obtaining data for the deep-learning team.

Bas Buijtenhuis is MRIguidance’s Customer Service & Support Engineer. The current company directory describes a biomedical-engineering and IT background used to support customers with technical needs involving BoneMRI. No undisclosed appointment date or executive position is inferred.

Bram Kooiman is a Deep Learning Engineer at MRIguidance. The current company directory identifies his work in deep learning and artificial intelligence for medical-imaging applications. His exact appointment date and any personal investment are not disclosed.

Dacina Crainic is MRIguidance’s Head of Software Engineering. The current issuer directory describes her work with development teams building software products for healthcare professionals and patient care. Her engineering leadership is distinct from an inferred corporate officer or investor role.

Dionysios Ziogas is MRIguidance’s Commercial Development Manager. The company describes his responsibility for global BoneMRI product strategy, combining health-economics knowledge and marketing expertise. The exact current spelling follows the named company directory and its linked professional profile.

Elco Oost is MRIguidance’s Product Integration Specialist. His current company biography covers application development and certification, product deployment and customer service, supporting the introduction of BoneMRI into clinical workflows.

Florian Calvet is MRIguidance’s DevSecOps Engineer. The current company directory describes implementing cloud technologies to make BoneMRI available to users while maintaining software security. No unpublished appointment date is inferred.

Harriet Weir is MRIguidance’s Clinical Commercial Specialist. Her current company biography describes combining biomedical engineering and commercial experience to connect clinicians with BoneMRI. No clinical licence or undisclosed executive title is inferred.

Huiqin Chen is MRIguidance’s Medical Device Software Engineer. The current issuer directory describes developing safe and reliable software applications for medical devices. The accessible directory does not link a personal profile, so unrelated professionals with the same name are not merged into this identity.

Iulia Lucaciu is MRIguidance’s QA Officer. Her current issuer biography describes a background in medical imaging and work developing and improving the quality management system against applicable regulations and guidelines.

Jasper van der Graaf is MRIguidance’s Clinical Affairs Manager. The current company directory describes using experience in MRI and orthopedic surgery to bring imaging solutions into clinical practice. This role does not itself establish a medical degree or personal equity investment.

Peter Seevinck is MRIguidance’s co-founder and CSO, an MR physicist and inventor of BoneMRI. He co-founded the business in 2016 and was interim CEO from early 2022 until January 2025. His current CSO work includes clinical validation, scientific and product innovation and intellectual property. UMC Utrecht independently confirms his academic research and co-founder identity. His personal scientific grants are distinct from company financing.

Guido Zijl became MRIguidance CEO in February 2026, succeeding Roel Kellenaers. The issuer describes more than 20 years of operational and commercial leadership in medical devices, most recently as a vice president at Globus Medical. The appointment month is verified; an exact effective day is not disclosed.

Marijn van Stralen is MRIguidance’s co-founder and CTO. An image scientist, he co-founded the UMC Utrecht spinout in 2016 with Peter Seevinck and Roel Raatgever. He leads medical-imaging and AI technology, the product roadmap and customer requirements. The issuer also named him among the founders temporarily covering CEO duties after Raatgever’s death in late 2021.

Eva Hukshorn is MRIguidance’s current CFO. The company announced her appointment as Chief Financial and Operations Officer on 18 October 2021, describing experience in scaling businesses and financial and operational management. The current directory uses the shorter CFO title.

MRIguidance is the Utrecht medical-imaging company legally identified as MRIguidance B.V. in FDA filings. MR physicist Peter Seevinck, image scientist Marijn van Stralen and entrepreneur Roel Raatgever founded it in 2016 as a University Medical Center Utrecht spinout. BoneMRI is its product and trademark, rather than a separately inferred company rename or acquisition. BoneMRI combines dedicated MRI acquisition and deep learning to generate three-dimensional CT-like bone images alongside aligned soft-tissue imaging. It supports radiology, musculoskeletal diagnostics and spine surgical planning and navigation without adding ionizing-radiation imaging. The software integrates with DICOM/PACS workflows through hospital or cloud processing. FDA record K233030 confirms a substantially-equivalent 510(k) clearance on 1 March 2024; scanner, anatomy and software-version indications apply. The February 2026 release describes spinal stitching, expanded scanner compatibility and IT improvements. Clinical superiority and market-leading statements remain attributed to the issuer. The current public directory names 20 management/staff members and three advisers. Guido Zijl succeeded Roel Kellenaers as CEO in February 2026; Seevinck is CSO and van Stralen CTO. Founder Raatgever died in late 2021, and the intervening leadership roles are recorded historically. Verified financing consists of a EUR1.5 million seed announced on 16 October 2018, a EUR750,000 bridge announced on 9 July 2020 involving an EIT Health co-investment grant in return for options and existing shareholders and a USD1.25 million Mammoth Scientific investment announced on 25 August 2021 through Mammoth Private Capital. EIT Health Bridgehead Global support in 2021 included a separate grant whose recipient-specific cash amount is undisclosed. Hospital customers, distribution partners, university collaborators and personal scientific grants are distinguished from company equity investments. A company-named NWO Take-off phase 2 development award dated 23 June 2017 is separately recorded with amount and instrument undisclosed; an award does not establish cash drawdown.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Co-founder and general partner of Tensility Venture Partners since 2016, focusing on infrastructure software and security. Previously an Apex Venture Partners general partner. Holds a University of Michigan MBA and a Caltech electrical-engineering degree.

Listed in Tensility Venture Partners’ current public team of advisors. The firm invests in early-stage AI-first software and services.

Co-founder and general partner of Tensility Venture Partners since 2016, focusing on application software and services. Previously an Apex Venture Partners general partner. Holds an MIT MBA and electrical-engineering degrees from UMass Amherst.

Tensility Venture Partners LLC is a Chicago early-stage venture capital manager focused on AI-first software and services. Its co-founders and general partners Wayne Boulais and Armando Pauker describe Tensility roles beginning in2016, following their earlier careers at Apex Venture Partners. The current public directory lists the two founders and14 advisors. The firm targets security, digital health, vertical industry applications and infrastructure, with current interests including agentic and physical AI, quantum, space and dual-use technologies. Its own portfolio separates TensilityI, II and III investments; the older portfolio and predecessor experience are distinct from the current legal manager. The SEC identifies the manager as CRD285242, an exempt reporting adviser, and lists its FundII and BrainCheck/ConverseNow co-investment vehicles. Reported regulatory asset values are not treated as fund closes or portfolio checks. A2026 TensilityIII filing reports USD2.205M sold against the same total offering, rather than an undisclosed larger flagship fund size.

Jason Pesterfield is an independent board director of Spiro Robotics. ElucentMedical’s current official leadership directory separately identifies him as president and CEO of its precision-guided surgical technology business. His Spiro governance affiliation and outside executive role are distinct; neither establishes that ElucentMedical or he personally invested in Spiro.

Barry Cheskin is a senior adviser to Spiro Robotics, according to its current core team directory. An issuer-submitted2023 Connectpreneur financing profile also lists him among the leadership of the handheld intubation-robot company. That historic company summary does not establish a current employee title, directorship or personal investment; his current role is recorded exactly as senior adviser.

Vladimir Nekhendzy is founder and a board director of Spiro Robotics. StanfordUniversity identifies him as a clinical professor of anesthesiology, perioperative and pain medicine and, by courtesy, otolaryngology. His clinical focus includes difficult and advanced airway management and anesthesia for head-and-neck procedures. He completed anesthesiology residency at UCSF in1996 and earned board certification in1997. His clinical expertise informs the company’s physician-guided airway technology.

Jackie Dulken is director of engineering and operations at Spiro Robotics. The officialFDA K253437 decision letter and device summary identify her as the company’s regulatory contact for Spiro-VISTA. The2024 federal STTR award also lists her as business contact. Her self-published profile records mechanical engineering-related study at CaliforniaPolytechnicStateUniversity, SanLuisObispo, including a2015–2016 VarianMedicalSystems sponsored design project.

Trae Gordon is chief commercial officer of Spiro Robotics, as named in its current core team directory. The company’s own announcement identifies him as representing its airway-management technology at the2026 MedTechStrategist Innovation Summit in Dublin. His role concerns commercial development of the handheld robotic intubation platform; unpublished prior employers or credentials are not inferred.

Dimitri Sokolov is CEO and a board director of Spiro Robotics. In his first-person2024 LSIUSA presentation he describes developing a handheld image-guided robot for difficult tracheal intubation, a completed4.5Mseed raise and plans for clinical development and an AI-assisted successor. The official2024 STTR award identifies him as principal investigator for the company’s airway-management research. The firm’s FDA-cleared2026 product and future autonomousAI roadmap are separate.

Spiro Robotics, Inc. is a Hayward, California medical-device company developing handheld robotics for airway management. Its Spiro-VISTA platform combines dual video imaging with a servo-controlled flexible intubation scope, a disposable laryngoscope blade and joystick controls to help qualified clinicians place an endotracheal tube. FDA510(k) K253437 received a substantial-equivalence decision on June12,2026, for use as an aid during difficult and non-difficult adult tracheal intubation in a hospital environment, for patients clinically evaluated for ETT inner-diameter sizes5.0–7.0mm. The cleared product uses operator controls; autonomous AI targeting and wider indications remain development plans rather than independently established cleared capabilities. Founder and Stanford clinical professor Vladimir Nekhendzy is joined by CEO Dimitri Sokolov, CCO Trae Gordon, engineering and operations director Jackie Dulken and senior adviser Barry Cheskin. The five-person board includes Sokolov, Nekhendzy, GoodGrowthCapital managing partner Amy Salzhauer, MQBPartners managing partner Caroline Quay and independent director Jason Pesterfield. Primary CEO2024 presentation reports a completed USD4.5M seed round; the proposed USD2M extension and later USD15–20M SeriesA target are not reported as cash closes. An official2024 STTR research award authorises USD109611, without evidence here of cash disbursement. MQB and GoodGrowth own portfolios confirm institutional backing; board memberships do not imply personal angel checks. The company is distinct from African electric-mobility company Spiro, Canadian SpiriRobotics, SpiroAI CRM and RespiroDiagnostics.

Pam Ryan appears in True Wealth Ventures’ published adviser and LP network. She founded Tingari Group and has written on venture-capital behavior, microfinance and social entrepreneurship, with prior leadership in psychology and public-policy organizations. This advisory affiliation is distinct from an employee role or undisclosed personal financial check.

Susan K. Nestegard is listed in True Wealth Ventures’ LP/adviser network. Her background includes technical, healthcare and operating leadership at Ecolab and a long career at3M. Outside-board affiliations mentioned in older biographies are historical context; current appointments are not inferred.

Kerry Rupp is a general partner of True Wealth Ventures. She previously led DreamIt, founded Holiday Golightly and held technology-company vice-president roles. She has taught NSF I-Corps entrepreneurship and earned an MBA at Harvard and bachelor’s degree at Duke.

Laurie Felker Jones is a visiting partner at True Wealth Ventures, working on fund and portfolio operations and impact. Her published background includes fractional operating-partner work and study at UT Austin, London School of Economics and Oxford. Other personal or alternative-fund projects do not automatically become True Wealth investments.

Sara T. Brand founded True Wealth Ventures and works with women-led health and environmental businesses on strategy, operations and governance. She previously worked in venture capital, consulting and technology-company operating roles and co-founded512Brewing. She studied mechanical engineering at UT Austin and green design/manufacturing at Berkeley.

True Wealth Ventures is an Austin-based early-stage venture capital firm investing in women-led companies that improve human or environmental health. Founding General Partner Sara T. Brand and General Partner Kerry Rupp combine venture, entrepreneurial, scientific and operating experience to support portfolio growth and governance. Its investments include cognitive-care software, behavioral-health AI, virtual-reality biofeedback, mobility assistance and other healthcare, sustainability and consumer-health technologies. Its own portfolio lists BrainCheck, PointHealth, Flowly, UnaliWear and the acquired De Oro Devices, among other businesses. Portfolio descriptions are investment themes rather than guarantees of clinical or commercial performance. The legal adviser is True Wealth Venture Capital, LLC, CRD285231, an exempt reporting adviser under the venture-capital-fund exemption. Its March2026 filing identifies thirteen legal fund vehicles: Fund I, Fund II, Fund II-A and ten co-investment series. Fund I closed at USD19.1 million in2018 and an oversubscribed USD35 million Fund II close was announced June28,2022. Earlier fundraising targets, parallel-vehicle allocations, regulatory asset values and the reported approximately USD60 million AUM are not additional closed capital. Its six named current published professionals include two general partners, a visiting partner and three listed LP/advisers; unnamed fellows and interns are not invented as individual team records.

San Francisco director of finance at Polaris since2018, overseeing management-company accounting. Earlier finance experience includes more than ten years as Hummer Winblad Venture Partners’ controller.

San Francisco executive assistant and office manager at Polaris since2025. Previous administrative roles include FCB Global, VantagePoint Capital and Intuit.

Polaris executive assistant to Terry McGuire since2002. Since2010 also co-founder and executive administrator of the Global Venture Capital Congress, coordinating its annual meetings.

New York executive assistant and office manager at Polaris since2024. Holds a comparative-literature degree from Brigham Young University and previously provided executive support in business aviation.